Introduction {#s1}
============

Kinetochores enable the precise distribution of chromosomes during the eukaryotic cell division to avoid aneuploidy ([@bib74]) which is associated with tumorigenesis, congenital trisomies and aging ([@bib4]; [@bib70]). Faithful segregation of the duplicated sister chromatids relies on their exclusive attachment to spindle microtubules emerging from opposite spindle poles ([@bib29]). The physical link between chromosomal DNA and microtubules is the kinetochore, a macromolecular protein complex that mediates the processive binding to depolymerizing microtubules driving the sister chromatids apart into the two emerging cells ([@bib6]; [@bib64]). Kinetochore assembly is restricted to centromeres, chromosomal domains that are marked by the presence of the histone H3 variant Cse4^CENP-A^ (human ortholog names are superscripted if appropriate) ([@bib25]; [@bib31]). In humans, regional centromeres span megabases of DNA embedding up to 200 CENP-A containing nucleosomal core particles (NCPs) ([@bib8]; [@bib64]). In contrast, *Saccharomyces cerevisiae* has point centromeres, which are characterized by a specific \~125 bp DNA sequence wrapped around a single Cse4-containing histone octamer ([@bib28]; [@bib10]; [@bib37]).

The budding yeast kinetochore is composed of about 45 core subunits which are organized in different stable complexes ([@bib20]; [@bib94]) of which several are present in multiple copies ([@bib49]). The kinetochore proteins are evolutionary largely conserved between yeast and humans ([@bib96]; [@bib87]) and share a similar hierarchy of assembly from DNA to the microtubule binding interface ([@bib20]). The centromere proximal region is established by proteins of the Constitutive Centromere Associated Network (CCAN), also known as the CTF19 complex (CTF19c) in budding yeast. The CTF19c comprises the Chl4/Iml3^CENP-N/L^, Mcm16/Ctf3/Mcm22^CENP-H/I/K^, Cnn1/Wip1^CENP-T/W^, Mhf1/Mhf2^CENP-S/X^ and Ctf19/Okp1/Mcm21/Ame1^CENP-P/Q/O/U^ (COMA) complexes plus Mif2^CENP-C^ ([@bib15]; [@bib94]; [@bib6]; [@bib64]) and the budding-yeast specific Nkp1/Nkp2 heterodimer. Another yeast inner kinetochore complex, the CBF3 (Ndc10/Cep3/Ctf13/Skp1) complex, has been identified as sequence-specfic binder of the centromeric DNA sequence CDEIII ([@bib65]; [@bib60]). The CTF19c^CCAN^ provides a cooperative high-affinity binding environment for the Cse4^CENP-A^-NCP ([@bib92]), where distinct subunits selectively recognize Cse4^CENP-A^ specific features. Across different species the CENP-C signature motif interacts with divergent hydrophobic residues of the CENP-A C-terminal tail ([@bib64]). Electron microscopy studies have recently resolved the interaction of CENP-N with the CENP-A centromere-targeting domain (CATD) in vertebrates ([@bib13]; [@bib34]; [@bib68]; [@bib18]; [@bib84]). For budding yeast Cse4, a direct interaction has so far only been demonstrated with Mif2 ([@bib94]; [@bib98]). Apart from Mif2, the only essential CTF19c^CCAN^ proteins are Ame1 and Okp1 ([@bib62]; [@bib67]; [@bib20]), with the N-terminus of Ame1 binding the N-terminal domain of Mtw1 and thus serving as docking site for the outer kinetochore KMN network (KNL1^SPC105^-/MIS12^MTW1^-/NDC80^NDC80^-complexes) ([@bib46]; [@bib23]).

The kinetochore is also a hub for feedback control mechanisms that ensure high fidelity of sister chromatid separation by relaying the microtubule attachment state to cell cycle progression, known as spindle assembly checkpoint (SAC), and by destabilizing improper kinetochore-microtubule attachments and selectively stabilizing the correct bipolar attachments, referred to as error correction mechanism ([@bib29]; [@bib58]). A major effector of both regulatory feedback loops is the kinase Ipl1^Aurora\ B^, a subunit of the evolutionary conserved tetrameric chromosomal passenger complex (CPC) which associates close to the centromere from G1 until anaphase ([@bib7]; [@bib97]; [@bib12]). The kinase subunit Ipl1^Aurora\ B^ binds to the C-terminal IN-box domain ([@bib1]; [@bib51]) of the scaffold protein Sli15^INCENP^, and Nbl1^Borealin^ and Bir1^Survivin^ form a three-helix bundle with the Sli15 N-terminus ([@bib56]; [@bib48]). All known mechanisms for recruitment of the CPC to the yeast centromere rely on Bir1, which directly associates with Ndc10 ([@bib19]) and is recruited through Sgo1 to histone H2A phosphorylated at S121 by Bub1 which so far has only been established in fission yeast ([@bib54]). Based on previous reports we refer to the CPC recruited through Ndc10 or H2A-P as centromere-targeted CPC pool, notwithstanding that the centromere-targeted Sli15^INCENP^ scaffold may extend to, and Ipl1^Aurora\ B^ may operate at, the kinetochore structure. CPC lacking the centromere-targeting domain (CEN) of Sli15^INCENP^ is indicated as inner kinetochore-localized CPC ([@bib57]; [@bib64]).

During early mitosis incorrect microtubule attachment states are resolved by Ipl1^Aurora\ B^ which phosphorylates Ndc80 and Dam1 sites within the microtubule binding interface and thereby reduces their affinity towards microtubules ([@bib15]; [@bib63]; [@bib95]; [@bib16]; [@bib21]; [@bib74]). The selective destabilization promotes the establishment of a correctly bi-oriented kinetochore configuration at the mitotic spindle, referred to as amphitelic attachment ([@bib82]). The spatial separation model for establishing biorientation ([@bib58]) implies that centromere-targeting of Sli15 allows substrate phosphorylation by Ipl1^Aurora\ B^ within the span of the Sli15^INCENP^ scaffold and that tension dependent intra-kinetochore stretching ([@bib50]) pulls the microtubule binding interface out of reach of Ipl1^Aurora\ B^ resulting in dephosphorylation of outer kinetochore substrates and stabilization of amphitelic kinetochore-microtubule attachments ([@bib61]; [@bib59]).

A recent study challenged this model by showing that a Sli15 mutant lacking the centromere-targeting domain, Sli15∆N2-228 (Sli15∆N), suppressed the deletion phenotypes of Bir1, Nbl1, Bub1 and Sgo1 that mediate recruitment of the CPC to the centromere ([@bib11]). In contrast to wild-type Sli15, which localized between sister kinetochore clusters, Sli15∆N showed weak localization overlapping with Nuf2 at kinetochores ([@bib11]). Apart from the altered localization, Sli15∆N was indistinguishably viable from wild-type and displayed no significant chromosome segregation defects ([@bib11]; [@bib38]). Similarly, a survivin mutant in chicken DT40 cells that failed to localize INCENP and Aurora B to centromeres from prophase to metaphase displayed normal growth kinetics ([@bib99]). These findings suggest that centromere-targeting of Sli15/Ipl1 is largely dispensable for error correction and SAC signaling. But a molecular understanding of how the inner kinetochore-localized Sli15∆N/Ipl1 retains its biological function is missing.

We describe here the use of chemical crosslinking and mass spectrometry (XLMS) ([@bib39]) together with biochemical reconstitution to characterize the CTF19c^CCAN^ subunit connectivity and the protein interfaces that establish a selective Cse4-NCP binding environment. Subunits of the COMA complex were previously implicated in CPC function at kinetochores ([@bib20]; [@bib57]) and the Sli15ΔN mutant showed synthetic lethality with deletions of Ctf19 or Mcm21 ([@bib11]). Thus, we investigated whether the COMA complex directly associates with Sli15/Ipl1. We demonstrate that the Cse4-N-terminus ([@bib17]) binds Ame1/Okp1 through the Okp1 core domain ([@bib76]) and that dual recognition of budding yeast Cse4-NCP is established through selective interactions of the essential CTF19c^CCAN^ proteins Mif2 and Ame1/Okp1 with distinct Cse4 motifs. We further show that Sli15/Ipl1 interacts with the Ctf19 C-terminus and that synthetic lethality upon Ctf19 depletion in the *sli15ΔN* background is rescued by fusing Sli15ΔN to the COMA complex. Our findings show contacts important for CTF19c^CCAN^ architecture assembled at budding yeast point centromeres and indicate that the interaction of CPC and COMA is important for faithful chromosome segregation.

Results {#s2}
=======

The Ame1/Okp1 heterodimer selectively binds Cse4 containing nucleosomes {#s2-1}
-----------------------------------------------------------------------

To screen for direct interaction partners of Cse4-NCPs we reconstituted the individual CTF19c^CCAN^ subcomplexes (Mif2, Ame1/Okp1, Ctf19/Mcm21, Chl4/Iml3, Mcm16/Ctf3/Mcm22, Cnn1/Wip1, Nkp1/Nkp2, Mhf1/Mhf2) with Cse4- or H3-NCPs in vitro. The CTF19c^CCAN^ complexes were purified either from bacteria or insect cells as homogenous and nearly stoichiometric complexes ([Figure 1B](#fig1){ref-type="fig"}). Consistent with a recent study ([@bib98]), using electrophoretic mobility shift assays (EMSA), we observed that Mif2 selectively interacted with Cse4-NCPs and not with H3-NCPs ([Figure 1A](#fig1){ref-type="fig"}). We also found that Ame1/Okp1 bound specifically to Cse4-NCPs ([Figure 1A](#fig1){ref-type="fig"}). The lack of interaction with H3-NCPs, which were reconstituted using the same 601 DNA sequence ([@bib81]), suggests that Ame1/Okp1 directly and selectively binds Cse4 and that the interaction does not require AT-rich DNA sequences as previously proposed ([@bib46]). In contrast to the EMSA titration of human CCAN complexes with CENP-A-NCP ([@bib92]) using 10 nM NCP mixed with up to 20-fold excess of the respective subcomplexes, we could not detect Cse4-NCP band shifts with Chl4/Iml3, the orthologs of human CENP-NL, and with Mcm16/Ctf3/Mcm22, the orthologs of human CENP-HIK (no *S. cerevisiae* ortholog of CENP-M has been identified) using 500 nM NCP incubated with a twofold excess of the complexes. Ctf19/Mcm21, Cnn1/Wip1, Nkp1/Nkp2 and Mhf1/Mhf2 did also not form distinct complexes with either Cse4- or H3-NCPs in the EMSA indicating that Mif2 and Ame1/Okp1 possess a higher relative binding affinity to Cse4-NCPs than the other CTF19c subcomplexes ([Figure 1A](#fig1){ref-type="fig"}).

![The heterodimeric Ame1/Okp1 complex directly and selectively binds the Cse4-NCP.\
(**A**) Electrophoretic mobility shift assays (EMSAs) of the indicated CTF19c^CCAN^ subunits and subcomplexes mixed in a 2:1 molar ratio with either Cse4- or H3-NCPs. DNA/protein complexes were separated on a 6% native polyacrylamide gel. The DNA is visualized by SYBR Gold staining. (**B**) Coomassie stained gel of the individual inner kinetochore components, recombinantly purified from *E. coli*, used in the EMSA in (**A**). (**C**) XLMS analysis of the in vitro reconstituted Cse4-NCP:Mif2:COMA:Chl4/Iml3:MTW1c complex. Proteins are represented as bars indicating annotated domains ([Supplementary file 3](#supp3){ref-type="supplementary-material"}) according to the color scheme in the legend. Subunits of a complex are represented in the same color and protein lengths and cross-link sites are scaled to the amino acid sequence.](elife-42879-fig1){#fig1}

To identify the binding interfaces of the Ame1/Okp1:Cse4-NCP complex we performed XLMS analysis. We reconstituted a complex on Cse4-NCP composed of Ame1/Okp1, Mif2, Ctf19/Mcm21, Chl4/Iml3 and the MTW1c which links the KMN network to the inner kinetochore receptors Ame1 and Mif2 ([@bib72]; [@bib78]; [@bib46]). Size-exclusion chromatography (SEC) analysis showed that MTW1c forms a complex with Ame1/Okp1, Mif2, Ctf19/Mcm21 and Chl4/Iml3 and the peak fraction shifted to a higher molecular weight upon addition of Cse4-NCPs depicting nearly stoichiometric protein levels of all subunits ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In all in vitro reconstitution and XLMS experiments we used wild-type MTW1c lacking the phosphorylation mimicking mutations of Dsn1 S240 and S250, which have been shown to stabilize the interaction with Mif2^CENP-C^ and Ame1^CENP-U^ ([@bib2]; [@bib23]), but were not required for complex formation on SEC columns ([Figure 2C](#fig2){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In total 349 inter-subunit crosslinks between the fifteen proteins were identified ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The majority of the crosslinks detected within the different subcomplexes MTW1c, COMA, Chl4/Iml3, and Cse4-NCP are in agreement with previous studies validating our crosslink map ([@bib20]; [@bib43]; [@bib46]). Moreover, crosslinks from the Mif2 N-terminus to the MTW1c ([@bib72]; [@bib78]), from the Mif2 Chl4/Iml3-binding domain to Chl4 ([@bib43]), and from the Mif2 signature motif to the Cse4 C-terminus ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}) ([@bib53]) are consistent with previously described interfaces. Crosslinks between Ame1/Okp1 and Cse4 occur exclusively between Okp1 and Cse4, suggesting that Okp1 is the direct binding partner of Cse4. Furthermore, Okp1 was the only COMA subunit that crosslinked to the three canonical histones H2A, H2B and H4 with the exception of one crosslink between Ame1 and H2A. Our analysis indicated a close association between Chl4/Iml3 and all COMA subunits. A direct interaction between COMA and Chl4 was reported previously and the Ctf19/Mcm21 heterodimer was found to be required for the kinetochore localization of Chl4 and Iml3 ([@bib76]).

![A short helical motif within the Cse4 N-terminus serves as Ame1/Okp1 docking site and is essential in vivo.\
(**A**) Multiple sequence alignment of Cse4^CENP-A^ proteins. Yeast protein sequences with the highest similarities to *S. cerevisiae* Cse4, three mammalian and the *S. pombe* homologous CENP-A protein sequences were included in the alignment. The amino acid (aa) patch, conserved in interrelated yeasts, is highlighted in pink (*S. cerevisiae* Cse4 aa 34--61). The RG motif in the mammalian sequences is indicated by arrowheads. Amino acid residues are colored and annotated according to the ClustalW color and annotation codes (S.: *Schizosaccharomyces*, C.: *Candida*, Z.: *Zygosaccharomyces*, L.: *Lachancea*). Residues that are identical among aligned protein sequences (\*), conserved substitutions (:), and semiconserved substitutions (.) are indicated. (**B**) Scheme of the deletion mutants within the Cse4 N-terminus used in the SEC experiments in (**C**) and (**D**) and in the cell viability assays in (**E**). The conserved region (aa 34--61) is highlighted in pink. (**C**) SEC analysis of the indicated mixtures of recombinant Ame1/Okp1 (AO) and MTW1c and reconstituted H3-, Cse4-, Cse4Δ2--30- or Cse4Δ31--60-NCPs. Ame1/Okp1, MTW1c and the Cse4 proteins were mixed equimolar. Eluted proteins were visualized by SDS-PAGE and Coomassie staining. (**D**) SEC analysis of Ame1/Okp1 (AO) preincubated with Cse4Δ34--46- or Cse4Δ48--61-NCPs. Eluted complexes were analyzed by SDS-PAGE and Coomassie staining. (**E**) Left panel: Cell growth assay of Cse4 mutants in budding yeast using the anchor-away system. The Cse4 wild-type and indicated mutant proteins were ectopically expressed in a Cse4 anchor-away strain (Cse4-FRB) and cell growth was monitored by plating 1:10 serial dilutions on YPD medium at 30°C in the absence or presence of 1 µg/ml rapamycin. Right panel: Western blot analysis of the ectopically expressed Cse4 wild-type and mutant protein levels in the yeast strains shown on the left. Pgk1 levels are shown as loading control.](elife-42879-fig2){#fig2}

The essential N-terminal domain of Cse4 is required for Okp1 binding {#s2-2}
--------------------------------------------------------------------

To further characterize the interaction between Ame1/Okp1 and Cse4-NCPs we aimed to identify the binding interface of the Ame1/Okp1:Cse4-NCP complex. Two crosslinks were detected between Okp1 and the essential Cse4 N-terminus ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). A multiple sequence alignment (MSA) of Cse4^CENP-A^ protein sequences ([Figure 2A](#fig2){ref-type="fig"}) detected a conserved region (ScCse4 aa 34--61), unique to Cse4 proteins of interrelated yeasts, which is almost identical to the so-called 'essential N-terminal domain' (END), aa 28--60, shown to be required for the essential function of the Cse4 N-terminus and for recruiting the 'Mcm21p/Ctf19p/Okp1p complex' to minichromosomes ([@bib55]; [@bib67]; [@bib17]).

To assess whether the Cse4 END mediates the interaction with Ame1/Okp1 we tested binding of recombinant Ame1/Okp1 to reconstituted wild-type and deletion mutants ([Figure 2B](#fig2){ref-type="fig"}) of Cse4- and to H3-NCPs by SEC ([Figure 2C](#fig2){ref-type="fig"}). Wild-type Cse4-NCP but not H3-NCP formed a stoichiometric complex with Ame1/Okp1 ([Figure 2C](#fig2){ref-type="fig"}) which is consistent with our EMSA and XLMS analyses ([Figure 1A,C](#fig1){ref-type="fig"}). In addition, Ame1/Okp1 bound to a Cse4-NCP retained the ability to interact with the MTW1c ([@bib46]), forming a direct link between the KMN network and the centromeric nucleosome ([Figure 2C](#fig2){ref-type="fig"}). Truncation of the first 30 N-terminal residues of Cse4 neither affected its ability to bind Ame1/Okp1, nor was it essential for viability ([Figure 2C](#fig2){ref-type="fig"}) ([@bib17]). However, the Cse4∆31--60 mutant abrogated Ame1/Okp1:Cse4-NCP complex formation ([Figure 2C](#fig2){ref-type="fig"}). To further narrow down the interface, two deletion mutants splitting the END in half, Cse4∆34--46 and Cse4∆48--61 ([Figure 2B](#fig2){ref-type="fig"}), were tested in SEC experiments. While Cse4∆48--61 associated with Ame1/Okp1, deletion of amino acids 34--46 completely disrupted the interaction ([Figure 2D](#fig2){ref-type="fig"}). All Cse4 N-terminal mutant and wild-type NCPs eluted at similar retention times from the SEC column indicating that the Cse4 N-terminal deletions did not affect Cse4 incorporation and stability of the nucleosomes ([Figure 2C,D](#fig2){ref-type="fig"}).

The crosslink-derived distance restraints as well as SEC analysis identified a conserved Cse4 peptide motif of amino acids 34--46 which is necessary for Ame1/Okp1 interaction. To test whether this motif is essential for cell viability, we depleted endogenous Cse4 from the nucleus using the anchor-away technique and performed rescue experiments by ectopically expressing the Cse4 mutants Cse4∆34--46 and Cse4∆48--61. Indeed, deletion of amino acids 34--46 was lethal, whereas the Cse4Δ48--61 mutant displayed wild-type growth rates ([Figure 2E](#fig2){ref-type="fig"}). The observation that deletion of the minimal Ame1/Okp1 interacting Cse4 motif (aa 34--46) correlates with the loss of cell viability, whereas the C-terminal half of the END (aa 48--61) is neither essential for viability nor required for Ame1/Okp1 association suggests that binding of the Ame1/Okp1 heterodimer to Cse4 residues 34--46 is essential for yeast growth. The Mif2 signature motif ([@bib98]) and Ame1/Okp1 recognize distinct motifs at the Cse4 C- and N-terminus ([Figure 1C](#fig1){ref-type="fig"}), respectively, and both are essential for viability ([@bib46]).

The Okp1 core domain interacts with Cse4 {#s2-3}
----------------------------------------

To characterize the Cse4 binding site in Okp1 we applied crosslink-derived restraints to narrow down the putative interface to amino acids 95--202 of Okp1 ([Figure 1C](#fig1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Based on MSA analysis of Okp1 sequences, this region harbors a conserved stretch (aa 127--184), including part of the previously described Okp1 core domain (aa 166--211) which is essential for cell growth and whose function is still elusive ([@bib76]) ([Figure 3A](#fig3){ref-type="fig"}). Furthermore, a secondary structure analysis predicted two alpha helices within the conserved domain (helix1 aa 130--140, helix2 aa 156--188) ([Figure 3A](#fig3){ref-type="fig"}). Thus, we designed three deletion mutants (Okp1Δ123--147, Okp1Δ140--170, Okp1Δ163--187) and purified all Okp1 mutant proteins in complex with Ame1 from *E. coli*. In EMSAs Ame1/Okp1Δ123--147 bound to Cse4-NCPs as well as did the wild-type Ame1/Okp1 complex, whereas Ame1/Okp1Δ140--170 associated only weakly and Ame1/Okp1Δ163--187 failed to associate with Cse4-NCPs ([Figure 3B](#fig3){ref-type="fig"}). These results are consistent with monitoring protein complex formation by SEC ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In addition, analysis of the Okp1 deletion mutants Δ123--147 and Δ163--187 in cell viability assays showed a tight correlation between their requirement for the interaction with Cse4 and being essential for yeast growth ([Figure 3C](#fig3){ref-type="fig"}) ([@bib76]). This finding further supports the notion that the recognition of the Cse4 nucleosome by Ame1/Okp1 is essential in budding yeast.

![The essential core domain of Okp1 is required for the interaction with Cse4-NCPs.\
(**A**) Multiple sequence alignment of Okp1 amino acid sequences from related yeast species. Amino acid residues of the conserved region are colored and annotated according to the ClustalW color and annotation codes. Green bars above the alignment represent alpha helical regions predicted by Jpred ([@bib24]). Lines below the alignment indicate the overlapping Okp1 deletion mutants analysed in (**B**) and (**C**). Residues that are identical among aligned protein sequences (\*), conserved substitutions (:), and semiconserved substitutions (.) are indicated. (**B**) EMSA assessing complex formation of Cse4-NCPs with Ame1/Okp1 including wild-type (wt) Okp1 and the indicated Okp1 deletion mutants. Recombinant Ame1/Okp1 complexes were tested in a 1:1 (1) and 2:1 (2) molar ratio with Cse4-NCPs. The DNA is visualized by SYBR Gold staining. (**C**) Cell viability assay of Okp1 deletion mutants using the anchor away (aa) technique. Yeast growth of either the untransformed (-) Okp1 anchor-away strain (Okp1-FRB) or of strains transformed with the indicated Okp1 rescue alleles was tested in 1:10 serial dilutions on YPD medium in the absence or presence of 1 µg/ml rapamycin for 72 hr at 30°C.](elife-42879-fig3){#fig3}

The COMA complex interacts with Sli15/Ipl1 through the Ctf19 C-terminus {#s2-4}
-----------------------------------------------------------------------

The COMA complex is composed of two essential, Ame1/Okp1, and two non-essential, Ctf19/Mcm21, subunits ([@bib67]; [@bib15]). Both, Ctf19 and Mcm21 contain C-terminal tandem-RWD (RING finger and WD repeat containing proteins and DEAD-like helicases) domains forming a rigid heterodimeric Y-shaped scaffold whose respective N-terminal RWDs of the tandems pack together as shown by a crystal structure of the *K. lactis* complex ([@bib77]). The *ctf19Δ* or *mcm21Δ* mutants become synthetically lethal in a *sli15ΔN* background ([@bib11]). Furthermore, Ame1 has been suggested to have a role in Sli15 localization close to kinetochores independently of Bir1 ([@bib57]). To investigate whether Sli15/Ipl1 associates with the COMA complex, in vitro reconstitution and XLMS analysis detected 98 inter-protein and 69 intra-protein crosslinks ([Figure 4A](#fig4){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). In particular, there were 10 crosslinks from the C-terminal RWD (RWD-C) domain of Ctf19 and 4 crosslinks from the Mcm21 RWD-C domain to the microtubule binding domain of Sli15 (aa 229--565) ([Figure 4A](#fig4){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}, [3](#supp3){ref-type="supplementary-material"}). In the Ame1/Okp1 heterodimer, we identified crosslinks from Sli15 to Okp1 and from Ipl1 to Ame1. The crosslink detected to lysine 366 of Okp1 is located near the identified Ctf19/Mcm21 binding site within Okp1 ('segment 1' aa 321--329) ([@bib76]) and thus is close to the RWD-C domains of Ctf19 and Mcm21. We verified the interaction of Sli15 and the Ctf19 RWD-C domain by in vitro binding assays. Sli15-2xStrep/Ipl1 was immobilized on Streptavidin beads and incubated with a 2-fold molar excess of either Ame1/Okp1 and Ctf19/Mcm21 using wild-type Ctf19 protein or a C-terminal deletion mutant Ctf19Δ270--369 (Ctf19ΔC). Ame1/Okp1 and Ctf19/Mcm21 were both pulled down with Sli15/Ipl1 either as individual complexes or in combination ([Figure 4B](#fig4){ref-type="fig"}). In agreement with previous findings ([@bib76]), recombinant Ctf19ΔC formed a stoichiometric complex with Mcm21, but lost its ability to bind Sli15/Ipl1 indicating that the RWD-C of Ctf19 is required for Sli15/Ipl1 interaction in vitro ([Figure 4C](#fig4){ref-type="fig"}). Autophosphorylation of Sli15/Ipl1 abrogated its interaction with Ame1/Okp1 and Ctf19/Mcm21 indicating that like the phosphorylation-regulated binding to microtubules, phosphorylation of Sli15 by Ipl1 may prevent and regulate its binding to the COMA complex ([Figure 4B](#fig4){ref-type="fig"}).

![The core-CPC Sli15/Ipl1 associates with the COMA complex through the Ctf19 C-terminal RWD domain in vitro.\
(**A**) Network representation of lysine-lysine cross-links identified on recombinant Sli15/Ipl1 in complex with COMA. Proteins are represented as bars indicating annotated domains ([Supplementary file 3](#supp3){ref-type="supplementary-material"}) according to the color scheme in the legend. Subunits of a complex are represented in the same color. Protein lengths and cross-link sites are scaled to the amino acid sequence. (**B**) In vitro binding assay analyzing the interaction of Sli15/Ipl1 with the COMA complex. Recombinant Sli15-2xStrep/Ipl1 was immobilized on Streptavidin beads and incubated with Ctf19/Mcm21, Ame1/Okp1 or Ame1/Okp1/Ctf19/Mcm21. Autophosphorylation (p) of Sli15/Ipl1 largely reduced bound protein levels. Dephosphorylation (dp) of Sli15/Ipl1 did not alter the bound proteins levels, which were visualized by SDS-PAGE and Coomassie staining. (**C**) In vitro binding assay analyzing the interaction of Sli15/Ipl1 with Ctf19/Mcm21 or Ctf19∆C/Mcm21. Ctf19∆C lacks the last 100 amino acids which form the C-terminal RWD domain. This panel is representative of three independent experiments.](elife-42879-fig4){#fig4}

In summary, crosslink-derived restraints identified the Ctf19 RWD-C domain as a Sli15/Ipl1 docking site within the COMA complex, a conclusion supported by the loss of interaction upon deletion of the Ctf19 C-terminus in vitro.

Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a *sli15ΔN* mutant upon Ctf19 depletion {#s2-5}
----------------------------------------------------------------------------------------------------------------

As deletions of Ctf19 or Mcm21 were synthetically lethal in a *sli15ΔN* background ([@bib11]) and Sli15 associated with the Ctf19 RWD-C in vitro ([Figure 4](#fig4){ref-type="fig"}), we investigated the relevance of this interaction by performing yeast viability assays. First, we reproduced the reported synthetic lethality by anchoring-away Ctf19-FRB in a yeast strain, in which the endogenous *SLI15* copy was replaced by *sli15ΔN* ([@bib36]). We found that in the presence of Ctf19-FRB, cells expressing Sli15ΔN are viable, but display synthetic lethality on rapamycin containing medium, consistent with previous findings ([@bib11]) ([Figure 5A](#fig5){ref-type="fig"}).

![Synthetic lethality of Sli15ΔN and Ctf19 depletion is rescued by fusing Sli15ΔN to Ame1/Okp1 and is independent of Ctf19's role in cohesin loading.\
(**A**)-(**D**) Cell viability assays studying the rescue of synthetic lethality of a *sli15ΔN/CTF19-FRB* strain using the anchor-away system. The indicated constructs were transformed into a Ctf19 anchor-away (aa) strain (Ctf19-FRB) carrying *sli15∆N* (∆N) at the endogenous locus (A, B, D,) or into a Sli15 anchor-away strain (Sli15-FRB) (**C**). Yeast growth was tested in serial dilutions either untransformed (-) or transformed with the indicated rescue constructs on YPD medium in the absence or presence of 1 µg/ml rapamycin at 30°C. The lower panels in (**B**), (**C**) and (**D**) show western blot analysis of the ectopically expressed protein levels. Pgk1 levels are shown as loading control. (**A**) Deletion of the Ctf19 N-terminus (Ctf19∆N2-30) does not affect cell viability in a *sli15∆N* background. (**B**) Artificial tethering of Sli15∆N to Ame1 or Okp1 rescued synthetic lethality of *sli15∆N* cells upon Ctf19-FRB depletion from the nucleus. (**C**) Growth phenotypes of Sli15 wild-type, Sli15∆SAH, Sli15∆N, and Sli15∆N∆SAH tested in a Sli15-FRB anchor-away strain. (**D**) Rescue of cell growth by ectopic Ame1-Sli15∆N or Okp1-Sli15∆N fusion proteins is dependent on the Sli15 Ipl1-binding domain (IN-box), whereas the SAH domain is dispensable.](elife-42879-fig5){#fig5}

Recently, the Ctf19 N-terminus has been identified as the receptor domain of the cohesin loading complex Scc2/4 in late G1 phase ([@bib42]). To address whether Sli15/Ipl1 has an active role in this process, we deleted 30 amino acids of Ctf19 (Ctf19ΔN2-30) which have been shown to contain phosphorylation sites of the Dbf4-dependent kinase required for Scc2/4 recruitment to the centromere ([@bib42]). Cells expressing Ctf19ΔN2-30 in the *sli15ΔN* background were just as viable upon depletion of Ctf19-FRB as those expressing intact Ctf19 ([Figure 5A](#fig5){ref-type="fig"}), demonstrating that the synthetic lethality is independent of the Ctf19 N-terminus and its role in cohesin loading.

If the synthetic effect is associated with the loss of interaction between Sli15ΔN and COMA, artificial tethering of Sli15ΔN to the kinetochore should restore growth. We generated fusions of Sli15ΔN to various inner and outer kinetochore proteins and investigated whether growth was restored in a *CTF19-FRB*/*sli15ΔN* background. Ectopic expression of Sli15ΔN fusions to the outer kinetochore subunits Mtw1 or Dsn1 and to the inner kinetochore subunits Mif2, Ctf3 or Cnn1 did not rescue viability ([Figure 5B](#fig5){ref-type="fig"}). But selectively tethering Sli15ΔN to Ame1 or Okp1 restored growth ([Figure 5B](#fig5){ref-type="fig"}).

We further tested whether the rescue of synthetic lethality depended on the Sli15 single alpha helix domain (SAH, aa 516--575) ([@bib73]; [@bib86]; [@bib27]) and the Ipl1 binding domain (IN-box, aa 626--698) ([@bib1]; [@bib52]). Both domains are essential for cell growth in the Sli15 wild-type or the *sli15ΔN* background ([Figure 5C](#fig5){ref-type="fig"}) ([@bib52]). Cells ectopically expressing the Sli15∆N mutant protein grew like wild-type, but displayed sensitivity to 15 µg/ml benomyl which contrasted the previous observation that cells carrying the endogenous *sli15ΔN* allele were not sensitive to 12.5 µg/ml benomyl ([@bib11]). These deviating observations may be a result of different experimental conditions. To distinguish the requirement of one domain from that of the other in the context of inner kinetochore-localized Sli15/Ipl1, we generated Ame1- and Okp1-Sli15ΔN fusion constructs in which either the IN-box or the SAH domain of Sli15ΔN had been deleted. While expression of Ame1- or Okp1-Sli15∆N∆SAH proteins rescued cell growth in the *sli15ΔN* background upon Ctf19 depletion, Ame1- and Okp1-Sli15∆N∆IN fusions did not, indicating that Ipl1 kinase activity is required ([Figure 5D](#fig5){ref-type="fig"}). Since the ectopically expressed fusion proteins were tested in the *sli15ΔN* background, the result indicates that Ipl1 activity associated with endogenous Sli15ΔN could not rescue synthetic lethality and that tethering Ipl1 activity to COMA subunits is crucial. In contrast, deletion of the SAH domain in Ame1- and Okp1-Sli15∆N∆SAH fusions was not lethal and was presumably rescued by the SAH domain of the endogenous Sli15ΔN protein ([Figure 5D](#fig5){ref-type="fig"}) suggesting that the SAH domain is not required for the function of the inner kinetochore-localized CPC pool.

Ame1- or Okp1-Ctf19 fusion proteins require the Ctf19 RWD-C domain to rescue synthetic lethality of a *sli15ΔN* mutant strain upon Ctf19 depletion {#s2-6}
--------------------------------------------------------------------------------------------------------------------------------------------------

Since the RWD-C domain of Ctf19 was required for association with Sli15/Ipl1 in vitro ([Figure 4C](#fig4){ref-type="fig"}), we asked whether its deletion would cause synthetic lethality with *sli15ΔN*. As recently described, the Ctf19 C-terminus is involved in formation of the COMA complex through binding to Okp1 ([@bib76]) and consequently, its deletion abrogates kinetochore localization of Ctf19 ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). To circumvent loss of Ctf19 from kinetochores, we tested whether Ame1 or Okp1 fusions to wild-type Ctf19 or Ctf19∆C were able to rescue synthetic lethality in the *sli15ΔN/CTF19-FRB* background. Fusions to both, the N- or C-terminus, of wild-type Ctf19 restored viability, whereas fusions to Ctf19∆C resulted in synthetic lethality ([Figure 6A](#fig6){ref-type="fig"}) suggesting that recruitment of Ipl1 activity to the inner kinetochore mediated by the Ctf19 C-terminus is important for CPC function.

![The Ctf19 C-terminus is important for chromosome segregation in the Sli15 wild-type background.\
(**A**) Left panel: Growth assay of the *sli15ΔN*/*CTF19-FRB* strain expressing Ame1-Ctf19, Ame1-Ctf19∆C, Okp1-Ctf19, Okp1-Ctf19∆C, Ctf19-Okp1 and Ctf19∆C-Okp1 fusion proteins from the rescue plasmid. Right panel: Western blot analysis visualizing the levels of the ectopically expressed, C-terminally 7xFLAG-tagged fusion proteins. Pgk1 levels are shown as loading control. (aa: Anchor-away) (**B**) Minichromosome loss assay. Chromosome segregation fidelity was determined in the Ctf19 anchor-away (*SLI15/CTF19-FRB*) strain, containing a minichromosome, either untransformed (-) or transformed with the indicated rescue constructs in the absence or presence of 1 µg/ml rapamycin. The percentage and standard error of red/red sectored colonies to the total colony number (white plus red/red sectored) of three biological replicates is shown. The results of 100% red colonies may be indicative of non-optimal conditions for the chromosome loss assay in combination with the anchor-away technique. (**C**) Localisation of ectopically expressed Ctf19-Okp1-GFP and Ctf19∆C-Okp1-GFP fusion proteins in the Ctf19 anchor-away strain (*SLI15/CTF19-FRB*) in the presence of 1 µg/ml rapamycin. Live cell fluorescence microscopy was performed 3 hr after rapamycin addition. Ndc80-mCherry was used as kinetochore marker. Merged mCherry and GFP signals are shown on the right. (BF: brightfield).\
10.7554/eLife.42879.012Figure 6---source data 1.Quantification of the minichromosome loss assay in a *SLI15*/*CTF19-FRB* strain.](elife-42879-fig6){#fig6}

Deletion of the Ctf19 RWD-C domain causes a chromosome segregation defect in the Sli15 wild-type background {#s2-7}
-----------------------------------------------------------------------------------------------------------

Since Ctf19 mutants display normal growth, but have chromosome segregation defects ([@bib47]), we tested whether the Ctf19 C-terminus is important for this function using the minichromosome loss assay ([@bib40]). The Ctf19 anchor-away strain was transformed simultaneously with the various Ctf19 rescue constructs and a centromeric plasmid carrying the *SUP11* gene as a marker which indicated loss of the minichromosome by red pigmentation ([@bib40]). Depletion of Ctf19 from the nucleus resulted in a severe chromosome segregation defect that was not observed by growing cells on medium lacking rapamycin which showed 4% red/sectored colonies ([Figure 6B](#fig6){ref-type="fig"}). Ectopic expression of the Ctf19 wild-type protein decreased the segregation defect to 19% red/sectored colonies ([Figure 6B](#fig6){ref-type="fig"}, [Figure 6B---source data 1](#fig6sdata1){ref-type="supplementary-material"}) and fusion of Okp1 to the C-terminus of wild-type Ctf19 reduced the red/sectored colonies to 32%. But the fusion of Okp1 to the Ctf19 N-terminus (Okp1-Ctf19 and Okp1-Ctf19∆C) did not rescue the segregation defect ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, [Figure 6B---source data 1](#fig6sdata1){ref-type="supplementary-material"}), indicating that the function of the Ctf19 N-terminus is compromised by fusing it to Okp1 ([Figure 6B](#fig6){ref-type="fig"}, [Figure 6B---source data 1](#fig6sdata1){ref-type="supplementary-material"}). Thus, the Ctf19-Okp1 fusion rescued the segregation defect, albeit to a slightly lesser extent than the Ctf19 wild-type protein. In contrast, Ctf19∆C-Okp1, which was localized at the kinetochore ([Figure 6C](#fig6){ref-type="fig"}), was unable to rescue the segregation defect ([Figure 6B](#fig6){ref-type="fig"}, [Figure 6B---source data 1](#fig6sdata1){ref-type="supplementary-material"}) suggesting that the Ctf19 C-terminus has a role in mediating accurate chromosome segregation.

Discussion {#s3}
==========

The Ame1/Okp1 heterodimer directly links Cse4 nucleosomes to the outer kinetochore {#s3-1}
----------------------------------------------------------------------------------

We investigated the subunit connectivity of the inner kinetochore assembled at budding yeast point centromeres at the domain level using in vitro reconstitution and XLMS. We found that in addition to Mif2 ([@bib98]), the Ame1/Okp1 heterodimer of the COMA complex is a direct and selective interactor of Cse4-NCPs. We identified the conserved motifs aa 163--187 of the Okp1 core domain ([Figure 3B,C](#fig3){ref-type="fig"}) ([@bib76]) and aa 34--46 ([Figure 2D,E](#fig2){ref-type="fig"}) of the Cse4 END to establish the interaction. Although, we did not address whether the Cse4 residues 34--46 are required for the Ame1/Okp1 kinetochore recruitment, the notion that the essential function of the Cse4 N-terminus and the binding interface for Ame1/Okp1 are mediated by the same 13 amino acid motif ([Figure 2](#fig2){ref-type="fig"}) suggests that Ame1/Okp1 is an essential link between centromeric nucleosomes and the outer kinetochore ([@bib46]).

Recent studies have identified the same Cse4 region to interact with Ame1/Okp1 ([@bib3]; [@bib44]). Anedchenko et al. found that the affinity of Cse4 N-terminal peptides to Ame1/Okp1 increases with the peptide length up to the low nanomolar range and that methylation of Cse4 R37 and acetylation of Cse4 K49 significantly reduces the binding affinity. Similarly, this region is regulated by Ipl1 phosphorylation in vivo and phosphorylation-mimicking mutants have been found to suppress temperature-sensitive Ipl1 and phosphorylation-deficient Dam1 und Ndc80 mutations ([@bib9]), and to decrease the affinity of a Cse4 peptide to Ame1/Okp1 ([@bib44]). This observation has interesting implications on the regulation of kinetochore assembly by Ipl1 destabilizing the Cse4-Ame1/Okp1 interaction in a cell cycle regulated manner. Moreover, weakening the interaction of Ame1/Okp1 with Cse4 may have a role in the tension sensing and error correction mechanisms ([@bib9]).

Dual recognition of Cse4 at point centromeres by a CTF19c^CCAN^ architecture distinct from vertebrate regional centromeres {#s3-2}
--------------------------------------------------------------------------------------------------------------------------

In vertebrates, CENP-NL and CENP-C, interact directly and specifically with CENP-A. CENP-C binds divergent hydrophobic residues at the CENP-A C-terminus, whereas CENP-N associates with the CENP-A CATD ([@bib13]; [@bib14]; [@bib34]; [@bib53]; [@bib92]; [@bib68]). Recently, electron microscopy reconstructions of human CENP-A nucleosomes in complex with CENP-N/L identified the RG motif in the L1 loops of the CATD ([@bib100]) as the CENP-N interaction site in CENP-A ([@bib68]; [@bib18]; [@bib84]). We did not detect complex formation of Chl4/Iml3 with Cse4-NCPs in our EMSA ([Figure 1A](#fig1){ref-type="fig"}). Whether this observation can be attributed to the lack of conservation of the RG motif in the corresponding Cse4 sequences in related budding yeasts ([Figure 2A](#fig2){ref-type="fig"}), and whether this reflects a different role of Chl4/Iml3 in Cse4 recognition and kinetochore assembly remains to be determined. Our crosslink-derived restraints are also in good agreement with a recent cryo-electron microscopy structure of a 13-subunit budding yeast inner kinetochore complex lacking the Cse4-NCP and Mif2 ([@bib44]) showing for instance crosslinks between the C-terminal domain of Chl4 and central regions of Ctf19 and Mcm21.

Similarly in humans, recruitment of the CENP-OPQRU complex to kinetochores requires a joint interface formed by CENP-HIKM and CENP-LN ([@bib30]; [@bib66]; [@bib69]), but loss of the complex does not affect localization of other inner kinetochore proteins. Differences between vertebrate and budding yeast inner kinetochores are reflected by the physiological importance of the involved proteins, as Ame1/Okp1 together with Mif2 are the essential CTF19c^CCAN^ proteins in budding yeast, whereas knockouts of CENP-U/Q in DT40 cells are viable ([@bib45]).

The Ctf19 C-terminus is required for Sli15/Ipl1 binding in vitro and has a role in accurate chromosome segregation {#s3-3}
------------------------------------------------------------------------------------------------------------------

Although the Ctf19/Mcm21 heterodimer is not essential, *ctf19∆* and *mcm21∆* mutants have chromosome segregation and cohesion defects ([@bib47]; [@bib67]; [@bib71]; [@bib26]; [@bib42]). Moreover, Ctf19 and Mcm21 become essential when centromere-targeting of the CPC is lost in a *sli15ΔN* mutant. This observation has led to the hypothesis that centromere-targeted Sli15 might be involved in cohesin loading or in cohesion maintenance ([@bib11]). An alternative model posits that COMA is required for the localization and positioning of Sli15/Ipl1 at the kinetochore ([@bib57]).

Our work showed that COMA interacts directly with Sli15/Ipl1 and identified the Ctf19 RWD-C domain as the primary docking site ([Figure 4A,C](#fig4){ref-type="fig"}). Synthetic lethality upon Ctf19 or Mcm21 depletion in a *sli15∆N* background was rescued by fusions of Sli15∆N to COMA subunits, whereas fusions to other inner or outer kinetochore proteins did not ([Figure 5B](#fig5){ref-type="fig"}). This observation suggests that positioning Sli15/Ipl1 proximal to Ame1/Okp1 is important in vivo. Because of the requirement of a functional Ipl1-binding IN-box on Sli15 for restoring viability we assume that the observed synthetic lethality is due to mislocalized Ipl1 kinase ([Figure 5D](#fig5){ref-type="fig"}). Tethering Sli15 to the inner kinetochore might ensure the spatial positioning of Ipl1 kinase activity towards outer kinetochore substrates ([@bib2]; [@bib29]; [@bib58]), required for correcting erroneous kinetochore-microtubule attachments ([Figure 7](#fig7){ref-type="fig"}). COMA-Sli15ΔN fusions lacking the SAH domain rescued growth, indicating that this domain is dispensable for CPC function at the inner kinetochore. Because the SAH domain is required for binding to spindle microtubules and critical for cell survival ([@bib73]; [@bib86]; [@bib27]), we infer that the observed rescue was mediated by the SAH domain of endogenous Sli15ΔN ([Figure 5D](#fig5){ref-type="fig"}).

![Schematic model of the budding yeast kinetochore subunit architecture.\
The Okp1 core domain directly binds the essential motif of the Cse4 END suggesting that in contrast to humans, the dual recognition of Cse4-NCPs in *S. cerevisiae* is established by the essential inner kinetochore subunits Ame1/Okp1 and Mif2 through interaction with distinct Cse4 motifs. Together with the observation that Ctf19 associates with Sli15/Ipl1, further CPC interactions with the inner and outer kinetochore could be part of a kinetochore conformation that is dependent on Sli15^INCENP^. In line with the observed benomyl sensitivity of cells expressing Sli15ΔN as the only nuclear copy ([Figure 5C](#fig5){ref-type="fig"}), a recent study in Xenopus egg extracts found that CPC lacking the CEN domain of INCENP affected the correction of erroneous kinetochore-microtubule attachments ([@bib35]). Centromere-targeting deficient CPC resulted in an imperfect inner kinetochore composition that failed to sense tension-loss and in intermediate Ndc80 phosphorylation levels that indicated the incapability of establishing a sharp phosphorylation gradient according to the spatial separation model. Flat Ndc80 phosphorylation levels could be sufficient for the non-selective turnover of erroneous kinetochore attachments, especially at budding yeast kinetochores which are attached to a single microtubule, unless cells are challenged by microtubule poisons.](elife-42879-fig7){#fig7}

We also showed that deletion of the Ctf19 RWD-C domain was sufficient to cause synthetic lethality with Sli15ΔN ([Figure 6A](#fig6){ref-type="fig"}) and that recombinant Ctf19∆C in complex with Mcm21 ([Figure 4C](#fig4){ref-type="fig"}) does not interact with Sli15. Moreover, assessing the initially proposed model for the synthetic growth defect of Ctf19/Mcm21 deletion in a *sli15ΔN* background ([@bib11]), we observed that deletion of the Ctf19 N-terminus did not cause a synthetic effect in *sli15ΔN* mutant cells. This result indicated that the synthetic growth defect is mediated by a Ctf19 domain distinct from its N-terminus and its role in cohesin loading.

Apart from the synthetic condition we addressed whether the Ctf19 C-terminus is required for chromosome segregation in Sli15 wild-type cells by monitoring missegregation in a minichromosome loss assay ([@bib40]). We showed that loss of the centromeric plasmid upon Ctf19 depletion was rescued to 70% by the ectopic expression of Ctf19-Okp1 and this rescue was abrogated upon deletion of the Ctf19 RWD-C domain in the fusion protein ([Figure 6B](#fig6){ref-type="fig"}). Similar observations have been obtained in a concomitant study ([@bib32]) using a complementary approach. By performing a \'centromere re-activation\' assay ([@bib83]) the Tanaka lab showed that Bir1 deletion, and to a lesser extent Mcm21 depletion, reduced localization of Ipl1 at the centromere which was synergistic upon removal of both and the effect on Ipl1 localization correlated with the establishment of chromosome biorientation. This is consistent with our finding that the Ctf19 C-terminus has a role in accurate chromosome segregation and indicates that the Sli15-Ctf19 interaction contributes to the localization and stabilization of the CPC at the inner kinetochore ([Figure 7](#fig7){ref-type="fig"}).

Our findings also agree with the observations that the functionally active Aurora B pool is associated with the kinetochore rather than the centromere ([@bib22]; [@bib5]; [@bib58]; [@bib41]). A recent study in humans demonstrated that a kinetochore-localized CPC pool lacking the INCENP CEN domain is sufficient to carry out error correction and biorientation, if cohesin removal, which was attributed to the loss of the CEN domain, is prevented ([@bib38]). Furthermore, retaining the human CPC at centromeres in anaphase resulted in the untimely recruitment of Bub1 and BubR1 ([@bib89]; [@bib88]) which suggests that centromere-localization of the CPC is required, and microtubule-association may not be sufficient, for fulfilling its function in the spindle assembly checkpoint and chromosome biorientation. The human CENP-OPQUR complex has recently been shown to promote accurate chromosome alignment by interaction with microtubules ([@bib69]). If the observed interaction between the CPC and COMA is conserved in higher eukaryotes or is facilitated by other kinetochore proteins remains to be addressed.

In the spatial separation model the CPC is anchored at the centromere and substrate access of the Ipl1^Aurora\ B^ kinase is regulated by tension-dependent intra-kinetochore stretching upon the biorientation of sister kinetochores. Whether the Ctf19-Sli15 interaction is required for CPC stabilization or for the precise positioning of Ipl1 activity at a distinct kinetochore conformation, competent for tension sensing and error correction, poses an interesting future question ([Figure 7](#fig7){ref-type="fig"}). Our findings place COMA at the center of kinetochore assembly in budding yeast and contribute to the molecular understanding of the fundamental process of how cells establish correct chromosome biorientation at the mitotic spindle.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                 Designation                                                             Source or\                                Identifiers                                                    Additional\
  (species) or\                                                                                                         reference                                                                                                information
  resource                                                                                                                                                                                                                       
  --------------------------------------------- ----------------------------------------------------------------------- ----------------------------------------- -------------------------------------------------------------- -------------
  Gene (*S. cerevisiae*)                        See [Supplementary file 5](#supp5){ref-type="supplementary-material"}                                                                                                            

  Strain, strain background (*S. cerevisiae*)   S288c                                                                                                                                                                            

  Strain, strain background (*E. coli*)         BL21(DE3)                                                               New England Biolabs                       C2527                                                          

  Strain, strain background (*E. coli*)         DH10Bac                                                                 ThermoFisher                              10361012                                                       

  Cell line (*S. frugiperda*)                   SF21; *Spodoptera frugiperda*                                           ThermoFisher                              11497013                                                       

  Cell line (*Trichoplusia ni*)                 High five; *Trichoplusia ni*                                            ThermoFisher                              B85502                                                         

  Genetic reagent (*S. cerevisiae*)             See [Supplementary file 5](#supp5){ref-type="supplementary-material"}                                                                                                            

  Antibody                                      Anti-FLAG M2 (mouse monoclonal)                                         Sigma-Aldrich                             F1804\                                                         1:5000
                                                                                                                                                                  RRID:[AB_262044](https://scicrunch.org/resolver/AB_262044)     

  Antibody                                      Anti-PGK1 (mouse monoclonal)                                            Invitrogen                                22C5D8\                                                        1:10000
                                                                                                                                                                  RRID:[AB_2532235](https://scicrunch.org/resolver/AB_2532235)   

  Antibody                                      goat anti-mouse IgG-HRP                                                 Santa Cruz Biotechnology                  sc-2005\                                                       1:10000
                                                                                                                                                                  RRID:[AB_631736](https://scicrunch.org/resolver/AB_631736)     

  Recombinant DNA reagent                       See [Supplementary file 4](#supp4){ref-type="supplementary-material"}                                                                                                            

  Peptide, recombinant protein                  3xFLAG peptide                                                          Ontores                                                                                                  

  Peptide, recombinant protein                  lambda phosphatase                                                      New England Biolabs                       P0753S                                                         

  Commercial assay or kit                       Q5 Site-Directed Mutagenesis Kit                                        New England Biolabs                       E0552S                                                         

  Chemical compound, drug                       BS3-H12/D12 cross-linker                                                Creative Molecules                        001SS                                                          

  Chemical compound, drug                       Iodoacetamide                                                           Sigma-Aldrich                             I6125                                                          

  Chemical compound, drug                       Lysyl Endopeptidase                                                     FUJIFILM Wako Pure Chemical Corporation   125--05061                                                     

  Chemical compound, drug                       Trypsin Sequencing Grade Modified                                       Promega                                   V5111                                                          

  Chemical compound, drug                       SYBR Gold                                                               ThermoFisher                              S11494                                                         

  Chemical compound, drug                       AMP-PNP                                                                 Santa Cruz Biotechnology                  CAS 72957-42-7                                                 

  Chemical compound, drug                       Rapamycin                                                               Invitrogen                                PHZ1235                                                        

  Chemical compound, drug                       Concanavalin A from *Canavalia ensiformis*                              Sigma-Aldrich                             C2010                                                          

  Chemical compound, drug                       FuGENE HD Transfection Reagent                                          Sigma-Aldrich                             E2311                                                          

  Chemical compound, drug                       cOmplete ULTRA EDTA-free Protease Inhibitor Cocktail                    Roche                                     5892953001                                                     

  Chemical compound, drug                       Ni-NTA Agarose                                                          Qiagen                                    30210                                                          

  Chemical compound, drug                       Strep-Tactin Superflow Plus Agarose                                     Qiagen                                    30004                                                          

  Chemical compound, drug                       M2 anti-FLAG agarose                                                    Sigma-Aldrich                             A4596                                                          

  Other                                         Sep-Pak tC18 cartridges                                                 Waters                                    WAT054960                                                      

  Other                                         PD-10 Desalting Columns                                                 GE Healthcare                             17085101                                                       

  Other                                         µ-Slide 8 Well                                                          Ibidi                                     80826                                                          

  Software, algorithm                           xQuest                                                                  ([@bib91])                                                                                               

  Software, algorithm                           xVis                                                                    ([@bib33])                                                                                               

  Software, algorithm                           Fiji                                                                    ([@bib75])                                                                                               

  Software, algorithm                           Clustal Omega                                                           ([@bib79])                                                                                               

  Software, algorithm                           SoftWoRx                                                                GE Healthcare                                                                                            
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Chemical cross-linking and mass spectrometry of kinetochore complexes {#s4-1}
---------------------------------------------------------------------

The complex containing Cse4-NCP, Mif2, Ame1/Okp1, Ctf19/Mcm21, Chl4/Iml3 and MTW1c was assembled in solution. It was cross-linked using an equimolar mixture of isotopically light (hydrogen) and heavy (deuterium) labeled bis\[sulfosuccinimidyl\]suberate (BS3, H12/D12) (Creative Molecules) at a final concentration of 0.25--0.5 mM at 10°C for 30 min. The reaction was quenched by adding ammonium bicarbonate to a final concentration of 100 mM for 10 min at 10 °C. The sample was subjected to SEC on a Superose 6 Increase 10/300 GL column (GE Healthcare) and the fractions corresponding to the cross-linked complex were selected for the subsequent protein digest and mass spectrometry (see below).

The complex of Sli15-2xStrep-HA-6xHis/Ipl1 with Ame1/Okp1 and Ctf19/Mcm21 was assembled on Strep-Tactin Superflow agarose (Qiagen) by incubation at room temperature (RT), 1000 rpm for 1 hr in a thermomixer (Eppendorf). Unbound proteins were removed by washing three times with binding buffer \[50 mM NaH~2~PO~4~(pH 8.0), 500 mM NaCl, 5% glycerol\] and the complex was eluted in binding buffer containing 8 mM biotin. The eluted complex was re-isolated on Ni-NTA beads (Qiagen), washed twice with binding buffer and then cross-linked by resuspending the protein bound beads in BS3 cross-linker at a final concentration of 0.25--0.5 mM at 30°C for 30 min. The cross-linking reaction was stopped by adding ammonium bicarbonate to a final concentration of 100 mM for 20 min at 30°C.

Cross-linked samples were denatured by adding two sample volumes of 8 M urea, reduced with 5 mM TCEP (ThermoFisher) and alkylated by the addition of 10 mM iodoacetamide (Sigma-Aldrich) for 40 min at RT in the dark. Proteins were digested with Lys-C (1:50 (w/w), FUJIFILM Wako Pure Chemical Corporation) at 35°C for 2 hr, diluted with 50 mM ammonium bicarbonate, and digested with trypsin (1:50 w/w, Promega) overnight. Peptides were acidified with trifluoroacetic acid (TFA) at a final concentration of 1% and purified by reversed phase chromatography using C18 cartridges (Sep-Pak, Waters). Cross-linked peptides were enriched on a Superdex Peptide PC 3.2/30 column using water/acetonitrile/TFA (75/25/0.1, v/v/v) as mobile phase at a flow rate of 50 μl/min and were analyzed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) using an Orbitrap Elite instrument (ThermoFisher). Fragment ion spectra were searched and cross-links were identified by the dedicated software *xQuest* ([@bib91]). The results were filtered according to the following parameters: Δscore ≤ 0.85, MS1 tolerance window of −4 to 4 ppm and score ≥ 22. The quality of all cross-link spectra passing the filter was manually validated and cross-links were visualized as network plots using the webserver *xVis* ([@bib33]).

Electrophoretic mobility shift assay {#s4-2}
------------------------------------

Reconstituted nucleosomes (0.5 µM) were mixed in a 1:2 molar ratio with the respective protein complexes in a buffer containing 20 mM Hepes (pH 7.5) and incubated for 1 hr on ice. The interaction was analyzed by electrophoresis at 130 V for 70--90 min on a 6% native polyacrylamide gel in a buffer containing 25 mM Tris and 25 mM boric acid. After electrophoresis, gels were stained with SYBR Gold (ThermoFisher).

Analytical size exclusion chromatography for interaction studies {#s4-3}
----------------------------------------------------------------

Analytical SEC experiments were performed on a Superdex 200 Increase 3.2/300 or a Superose 6 Increase 3.2/300 column (GE Healthcare). To detect the formation of a complex, proteins were mixed at equimolar ratios and incubated for 1 hr on ice before SEC. All samples were eluted under isocratic conditions at 4°C in SEC buffer \[50 mM HEPES (pH 7.5), 150 mM NaCl, 5% glycerol\]. Elution of proteins was monitored by absorbance at 280 nm. 100 µl fractions were collected and analyzed by SDS-PAGE and Coomassie staining.

In vitro protein binding assay of Sli15/Ipl1 to Ame1/Okp1 and/or Ctf19/Mcm21 {#s4-4}
----------------------------------------------------------------------------

Phosphorylated or non-phosphorylated wild-type or mutant Sli15-2xStrep-HA-6xHis/Ipl1 was immobilized on Strep-Tactin Superflow agarose (Qiagen). For prephosphorylation, Sli15/Ipl1 was incubated at 30°C for 30 min in the presence of 3 mM MgCl~2~ and 3 mM ATP. Samples for non-phosphorylated Sli15/Ipl1 were treated the same way, but instead of 3 mM ATP the non-hydrolysable analog AMP-PNP (Santa Cruz Biotechnology) was applied. To remove basal phosphorylation, Sli15/Ipl1 was treated with lambda phosphatase (New England Biolabs) at 30°C for 30 min. Subsequently, non-phosphorylated as well as phosphorylated or dephosphorylated Sli15/Ipl1 complexes were washed three times with binding buffer \[50 mM NaH~2~PO~4~(pH 8), 120 mM NaCl, 5% glycerol\].

Testing of binding between Ame1/Okp1, Ctf19/Mcm21 and Sli15/Ipl1 was performed in binding buffer at 4°C, 1000 rpm for 1 hr in a thermomixer (Eppendorf). Unbound proteins were removed by washing three times with binding buffer. The complexes were either eluted with 8 mM biotin in 50 mM NaH~2~PO~4~(pH 8), 500 mM NaCl, 5% glycerol or by boiling in 2x SDS loading buffer.

To quantify the ratios of bound proteins to the bait protein SDS page band intensities were analyzed by using the Fiji software ([@bib75]).

Amino acid sequence alignment {#s4-5}
-----------------------------

Multiple sequence alignment of Cse4 or Okp1 protein sequences from interrelated budding yeast species was conducted with Clustal Omega ([@bib79]). Only protein sequences with the highest similarity to *S. cerevisiae* Cse4 or *S. cerevisiae* Okp1 as determined by a protein BLAST search were included in the search. In addition three mammalian and the *Schizosaccharomyces pombe* homologous CENP-A protein sequences were included in the Cse4 alignment.

Yeast strains and methods {#s4-6}
-------------------------

All plasmids and yeast strains used in this study are listed in [Supplementary file 4](#supp4){ref-type="supplementary-material"} and [Supplementary file 5](#supp5){ref-type="supplementary-material"}, respectively. Yeast strains were created in the S288c background. The generation of yeast strains and yeast methods were performed by standard procedures. The anchor-away technique was performed as previously described ([@bib36]).

For anchor-away rescue experiments, the respective promoters and coding sequences were PCR amplified from yeast genomic DNA and cloned into the vector pRS313 either via the Gibson assembly or the restriction/ligation method. In order to artificially target Sli15∆N2-228 to the kinetochore, the individual promoters and genes were PCR amplified and the respective gene fusions \[*CTF19*, *AME1*, *OKP1*, *CTF3*, *CNN1*, *MIF2*, *DSN1*, *MTW1*\]-\[*SLI15∆N2-228*\]-\[*6xHis-7xFLAG*\] ([Supplementary file 4](#supp4){ref-type="supplementary-material"}) were generated and cloned into pRS313 using the Gibson assembly reaction The same strategy was applied in order to generate the *CTF19* or *CTF19∆C* gene fusions to *AME1* or *OKP1*, respectively ([Supplementary file 4](#supp4){ref-type="supplementary-material"}).

The individual deletion mutants were generated using the Q5 site-directed mutagenesis kit (New England Biolabs). The rescue constructs were transformed into Cse4-, Ctf19-, Okp1-, or Sli15 anchor-away strains ([Supplementary file 5](#supp5){ref-type="supplementary-material"}) and cell growth was tested in 1:10 serial dilutions on YPD plates in the absence or presence of rapamycin (1 µg/ml) at 30°C for 3 days.

Minichromosome loss assay {#s4-7}
-------------------------

The Ctf19 anchor-away strain containing a minichromosome (*pYCF1/CEN3.L*) ([@bib80]) and the Ctf19 anchor-away strains containing a minichromosome (*pYCF1/CEN3.L*) and the respective rescue plasmid were grown overnight in selective medium (-Ura selecting for the minichromosome, or --His/-Ura selecting for the rescue plasmid and the minichromosome) and then diluted into YPD medium and cultured for 4 hr. The yeast cultures were then plated onto synthetic medium containing rapamycin (1 µg/ml) and low (6 µg/ml) adenine to enhance the red pigmentation ([@bib40]) and incubated for 3 days at 30°C. Colonies retaining the minichromosome are white, and loss events result in the formation of red/red sectored colonies. The minichromosome loss frequency was quantified by determining the percentage of red/red sectored colonies in relation to the total colony number (white and red/red sectored) of three biological replicates.

Western blot analysis {#s4-8}
---------------------

For western blot analysis an equivalent of 10 OD~600~ of cells logarithmically grown in liquid culture was collected by centrifugation at 3140 x g for 5 min at RT and the pellet was washed once with aqua dest. For protein extraction, the pellet was resuspended in 1 ml ice-cold 10% trichloroacetic acid and incubated on ice for 1 hr. Samples were pelleted at 20000x g for 10 min, 4°C and washed twice with ice-cold 95% ethanol. Pellets were air-dried and resuspended in 100 µl 1x SDS-PAGE sample buffer containing 75 mM Tris (pH 8.8). Samples were boiled (10 min, 95°C) and centrifuged at 10800 x g for 3 min at RT and supernatants were separated on 10% or 15% (Cse4 containing samples) SDS-PAGE gels. Immunoblotting was performed with the following antibodies: Anti-FLAG M2 (Sigma-Aldrich), Anti-PGK1 (ThermoFisher) and visualized by HRP-conjugated anti-mouse secondary antibodies (Santa Cruz).

Live cell microscopy {#s4-9}
--------------------

For localisation analysis of endogenously tagged Ctf19-GFP and Ctf19∆C-GFP proteins, cells were grown in synthetic medium without tryptophan at 30°C. For localisation analysis of ectopically expressed Ctf19-Okp1-GFP and Ctf19∆C-Okp1-GFP proteins in the Ctf19-anchor-away (Ctf19-FRB) strain, cells were grown in selective medium (--His/-Trp) until OD~600~ \~0.4, then rapamycin (1 µg/ml) was added and cells were grown for another 3 hr at 30°C. For imaging cells were immobilized on concanavalin-A (Sigma-Aldrich) coated slides (Ibidi). Microscopy was performed using a DeltaVision microscopy system (Applied precision) with a Olympus IX71 microscope controlled by softWoRx software (GE Healthcare). Images were processed using Fiji ([@bib75]).

Protein expression and purification {#s4-10}
-----------------------------------

Expression constructs for 6xHis-Chl4/Iml3, 6xHis-Cnn1/Wip1-1xFlag, 6xHis-Nkp1/Nkp2 and Mhf1/Mhf2-1xStrep were created by amplification of genomic DNA and cloned into pETDuet-1 vector (Novagen). Expression was performed in BL21 (DE3) cells (New England Biolabs). Cells were grown at 37°C until OD~600~ 0.6, followed by induction with 0.5 mM IPTG for Chl4/Iml3 or 0.2 mM IPTG for all other protein expressions. Protein expression was induced overnight at 18°C, or for 3 hr at 23°C, respectively.

Cells were lysed using a French Press in lysis buffer \[50 mM Hepes (pH 7.5), 400 mM NaCl, 3% glycerol, 0.01% Tween20 and cOmplete ULTRA EDTA-free Protease Inhibitor Cocktail (Roche)\]. 6xHis-tagged proteins were purified using Ni-NTA agarose (Qiagen), whereby 30 mM imidazole were added to the lysis buffer in the washing step, followed by protein elution in 50 mM Hepes pH 7.5, 150 mM NaCl, 300 mM imidazole, and 5% glycerol. Strep-tag purification was performed using Strep-Tactin Superflow agarose (Qiagen) and eluted in a buffer containing 50 mM Hepes (pH 7.5), 150 mM NaCl, 8 mM biotin and 5% glycerol.

Buffer exchange into a buffer containing 50 mM Hepes (pH 7.5), 150 mM NaCl and 5% glycerol was performed using a Superdex 200 HiLoad 16/60 column (GE Healthcare) for Chl4/Iml3 and Cnn1/Wip1 or using a PD10 desalting column (GE Healthcare) for Nkp1/2 and Mhf1/2 protein complexes.

Ame1/Okp1 expression and purification {#s4-11}
-------------------------------------

Ame1-6xHis/Okp1 wild-type and mutant protein expression and purification in *E. coli* was performed as described previously ([@bib46]).

In vitro reconstitution of Cse4- and H3-NCPs {#s4-12}
--------------------------------------------

Octameric Cse4 and H3 containing nucleosomes were *in vitro* reconstituted from budding yeast histones which were recombinantly expressed in *E. coli* BL21 (DE3) and assembled on 167 bp of the \'Widom 601\' nucleosome positioning sequence according to a modified protocol ([@bib85]).

Affinity-purification of recombinant protein complexes from insect cells {#s4-13}
------------------------------------------------------------------------

C-terminal 6xHis-6xFLAG-tags on Mcm21, Mif2, Dsn1, Mcm16 and C-terminal 2xStrep- tags on Sli15 were used to affinity-purify Ctf19/Mcm21, Mif2, MTW1c, CTF3c and Sli15/Ipl1 complexes. Open reading frames encoding the respective subunits were amplified from yeast genomic DNA and cloned into the pBIG1/2 vectors according to the biGBac system ([@bib93]). The pBIG1/2 constructs were used to generate recombinant baculoviral genomes by Tn7 transposition into the DH10Bac *E. coli* strain (ThermoFisher) ([@bib90]). Viruses were generated by transfection of Sf21 insect cells (ThermoFisher) with the recombinant baculoviral genome using FuGENE HD transfection reagent (Promega). Viruses were amplified by adding transfection supernatant to Sf21 suspension cultures. Protein complexes were expressed in High Fiveinsect cell (ThermoFisher) suspension cultures.

For purification of FLAG-tagged kinetochore complexes, insect cells were extracted in lysis buffer \[50 mM Tris (pH 7.5), 150 mM NaCl, 5% glycerol\] supplemented with cOmplete ULTRA EDTA-free Protease Inhibitor Cocktail (Roche) using a Dounce homogenizer. Cleared extracts were incubated with M2 anti-FLAG agarose (Sigma-Aldrich) for 2 hr, washed three times with lysis buffer and eluted in lysis buffer containing 1 mg/ml 3xFLAG peptide (Ontores).

High Five cells expressing Strep-tagged Sli15/Ipl1 were lysed in 50 mM NaH~2~PO~4~(pH 8.0), 300 mM NaCl, 5% glycerol supplemented with cOmplete ULTRA EDTA-free Protease Inhibitor Cocktail (Roche). Subsequent to incubating the cleared lysates with Strep-Tactin Superflow agarose (Qiagen), protein bound beads were washed three times with lysis buffer and the bound protein complex was eluted in lysis buffer containing 8 mM biotin. FLAG peptide or biotin was either removed via PD10 desalting columns (GE Healthcare) or SEC using a Superdex 200 HiLoad 16/60 column (GE Healthcare) and isocratic elution in lysis buffer.
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The mass spectrometry raw data was uploaded to the PRIDE Archive and is publicly available through the following identifiers: PXD011235 (COMA-Sli15/Ipl1); PXD011236 (CCAN).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The COMA complex is required for positioning Ipl1 activity proximal to Cse4 nucleosomes in budding yeast\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Jennifer G. DeLuca as the Reviewing Editor and Reviewer \#3, and the evaluation has been overseen by Anna Akhmanova as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Sue Biggins (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, the authors investigate the organization of the budding yeast kinetochore using a combination of biochemical reconstitution and chemical crosslinking/mass spec (XMLS). In doing so, they identify novel interactions within the kinetochore and additionally, they map a direct binding site for the Chromosomal Passenger Complex (CPC) to the inner kinetochore. Specifically, they make two key findings: (1) They demonstrate an interaction between the N-terminus of Cse4 (the yeast homolog of CENP-A) and Okp1 (a member of the COMA complex). The interaction interfaces they identify are essential, underscoring the role these interactions play in kinetochore assembly. (2) They find that the C-terminal RWD of Ctf19 (also a member of the COMA complex) binds the CPC component Sli15 (the yeast homolog of INCENP). This is a major finding because it had been previously shown that CPC localization to the inner centromere is not essential for viability. Based on genetic experiments, the authors demonstrate that this may be due to a second CPC binding site in Ctf19 that can support viability when the inner centromere localization is disrupted. In addition, the authors show that the interaction between Ctf19 and Sli15 is regulated by inhibitory Ipl1/Aurora B phosphorylation. Overall, the reviewers were positive about the work and agree that this study provides important new information regarding the organization of eukaryotic kinetochores and defines a new mechanism for CPC recruitment to the kinetochore region. The reviewers also raise concerns regarding interpretation of the major findings, and in particular, three areas require significant attention.

First, the authors place great weight on the apparent absence of direct contact between Chl4 and Cse4. From this, they wish to infer large structural differences between the human and yeast inner kinetochore. These claims depend on the reconstitution recapitulating faithfully the assembly as it occurs inside the yeast nucleus. This may not be the case, for several reasons: (a) use of 601 DNA instead of a true centromere, (b) absence of post-translational regulation, and (c) lack of ordered assembly afforded by a single-mixture approach. Indeed, if the authors have isolated a true inner kinetochore assembly upon Cse4 (which would be a substantial step forward), they should show that it survives purification with the appropriate stoichiometry. Without such evidence, the discussion of XLMS findings must be tempered appropriately. It is also noted that in Figure 2 of Weir et al., in which similar XLMS studies were done with human proteins, there is only a single crosslink between CENP-N and CENP-A, and that link comes from the \"wrong end\" (the C-terminal end) of CENP-A. We nonetheless know from the work of Musacchio and Luger that CENP-N binds selectively with CENP-A nucleosomes. So, the absence of a crosslink cannot be taken as evidence that the structures differ in any major way. The conclusion that there is some important structural difference between human and yeast should be removed in favor of a far more nuanced statement. There are evidently some differences, either in assembly hierarchy or in pairwise affinities; in view of the divergence of sequences between orthologs, the absence of Nkp1/2 in metazoans, etc., it would be very surprising if there were not. But the current data do not tell us anything about those issues, subtle or otherwise.

Second, the authors point to the inability of kinetochore components besides Okp1 and Ame1 to rescue the viability of Sli15dN cells upon depletion of Ctf19 as evidence that Sli15 must be positioned at the inner kinetochore to carry out its function. A true test of this hypothesis would require a Ctf19 allele that disrupts Sli15 binding but does not affect outer kinetochore assembly. Ctf19 depletion causes removal of much of the outer kinetochore, making the presented experiment a poor test of the model. Furthermore, the authors do not present evidence that disruption of this specific interaction leads to the expected consequences in cells, namely defects in chromosome bi-orientation or error correction. This would go a long way in strengthening the authors\' conclusions.

Third, numerous studies have provided evidence for multiple distinct populations of the CPC in mitotic cells, including at the inner centromere, the kinetochore, spindle microtubules, and the spindle midzone. The authors, in identifying a binding site for CPC in the inner kinetochore, seem to have made major progress towards separating these CPC populations. Unfortunately, discussion of this issue is missing. That Sli15dN does not support full viability on benomyl (Figure 5E) seriously confounds the issue. How do the authors reconcile this finding with that of Campbell and Desai, which shows the opposite? What does this imply about the existence of distinct CPC populations? Which one might be responsible for tension sensing? Related to this point, there is confusion throughout the manuscript as to whether the authors are intending to differentiate between specific populations of the CPC, and whether they attribute loss of function/viability to one population or another. This becomes a critical issue when interpreting how different pools of the CPC are recruited to and functionally utilized at the centromere and kinetochore, a point that seems central to this study.

These are complex issues, and full answers may not be available. Nevertheless, the findings presented provide new information that will allow many laboratories to ask specific questions about CPC function in chromosome condensation, tension sensing, and kinetochore assembly in mitosis and meiosis. For this reason, the reviewers are in support of publication, and they agree that these issues can be addressed through a limited number of experimental revisions as well as major revisions to the text and figures.

Essential revisions (experimental):

1\) The discovery of a potentially new binding site for the CPC at the inner centromere is an important advance, but there is no demonstration that this interaction site exists in vivo, nor what the phenotypes of impairing this interaction are. While the tethering experiments are compelling, the authors \"anchor-away\" the entire Ctf19 protein, which leaves open the possibility that the phenotypes are due to multiple Ctf19 functions. An attempt to analyze Ipl1 localization in vivo or show that error correction requires the interaction between Ipl1 and Ctf19 would strengthen the findings. Ideally, the authors would use their conditional system to show that the mutation of the Ctf19 binding site eliminates all Ipl1 from kinetochores when the Sli15 N-terminus is mutated. At a minimum, the authors should analyze bi-orientation in a Sli15 mutant in the Ctf19 binding site to show that the cells are dying due to a bi-orientation defect as expected.

2\) It is difficult to see some of the proposed interactions in Figure 4B \-- quantification of this binding experiment would be useful. An additional issue with this figure, which is crucial to the manuscript as a whole, is that pulled-down material for single inputs alone (Sli15/Ipl1, Ame1/Okp1, Ctf19/Mcm21, etc.) are not shown, making the experiment difficult to interpret. These controls should be included.

3\) The authors demonstrate that phosphorylation of Sli15 by Ipl1 negatively regulates CPC binding to Ctf19, but there is no indication that this is physiologically relevant. If possible, the authors should test if the phospho-mutants (or mimics) have an effect on viability or chromosome segregation.

4\) Related to the above point, the authors expressed Sli15-Ipl1 in insect cells and show basal phosphorylation. Might there be some level of phosphorylation that impacts COMA interaction before ATP treatment? It would be informative to test if the interaction is positively affected after treatment with lambda phosphatase.

5\) Figures 2D, 5D and 5E: Immunoblots to demonstrate protein expression should be included.

Essential revisions (non-experimental):

1\) \"Epigenetically marked\" is inappropriate for budding yeast.

2\) Introduction, third paragraph: The end of this paragraph needs to be rewritten. The authors say that Campbell showed Sli15dN could still localize to kinetochores. They then discuss centromere-targeting deficient Sli15/Ipl1. Which is it? If the authors are referring to distinct Sli15/Ipl1 pools (kinetochore versus centromere?), then they should make the reference to distinct pools explicit and substantiate them with the proper references.

3\) Introduction, last paragraph: Topology is the wrong word.

4\) \"The interaction is not mediated by AT-rich DNA sequences\" should say, \"The interaction does not require AT-rich DNA sequences.\"

5\) Subsection "The Ame1/Okp1 heterodimer selectively binds Cse4 containing nucleosomes", last paragraph: The authors describe crosslinks between Mif2n and MIND. Did they use the Dsn1-2D mutant? If not, they should comment on the prevalence of these crosslinks relative to expectations. Why do they see them at all?

6\) Results, subsection "The Ame1/Okp1 heterodimer selectively binds Cse4 containing nucleosomes" last paragraph: \"no direct interaction\" is not formally correct. See Schmitzberger, 2017 supplement.

7\) The following is not a correct conclusion: \"Chl4, in contrast to its human ortholog, does not recognize Cse4-NCPs.\" The strongest claim that can be made is that the authors have not found evidence supporting this idea. Nor do the published XLMS data for the human ortholog provide such evidence \-- only direct binding and a structure. One could imagine a number of reasons for absence of crosslinks: no lysine pairs accessible to BS3 link Chl4 and Cse4; 601 is an inappropriate DNA substrate to use for these studies; post-translational modifications are required for Chl4-Cse4 engagement. In short, although the data are clear on many points and extremely valuable overall, they cannot prove the negative.

8\) \"END domain\" is redundant.

9\) \"suggests that recruitment of the Ame1/Okp1 heterodimer\" This should be rewritten to clarify the point that the suggested recruitment relationship between Cse4-END and Okp1-Ame1 is the speculation here. This modification is important; although the evidence presented is consistent with recruitment (Okp1-Ame1 by Cse4), no conclusive test of such a relationship is presented. An alternative hypothesis -- that Cse4-END regulates an essential function of either Okp1-Ame1 or Cse4 -- is equally likely given the data.

10\) \"Ctf19 is the primary Sli15/Ipl1 interaction site \[...\]\" This statement is too strong. Instead, it should read \"is required for Sli15/Ipl1 interaction\"

11\) Subsection "Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a sli15ΔN mutant upon Ctf19 depletion", last paragraph: This paragraph should be split into at least two and possibly three or four paragraphs.

12\) Subsection "Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a sli15ΔN mutant upon Ctf19 depletion", last paragraph: That Ctf19dN is not synthetic with Sli15dN is both interesting and important. If impaired cohesin loading does not explain the synthetic interaction with Ctf19d (as apparently it does not), how would the authors interpret the finding from Campbell and Desai that Ctf19d is synthetic with Sli15dN? When this finding was originally presented, it was framed as evidence for the cohesin hypothesis, which here seems discredited. A single sentence in the Discussion section would be appropriate.

13\) \"Endogenous Sli15dN could not rescue in trans \[...\]\" and \"In contrast, deletion of the SAH domain in Ame1- and Okp1-Sli14dNdSAH fusions was not lethal and could be rescued in trans.\" These statements are vague. Could not be rescued by what in trans? I suspect this is a reference to later Campbell work (Fink et al., 2017) showing that induced dimerization of Sli15 rescues viability of cells expressing more perturbative Sli15dN alleles (d2-500, for instance). If so, this should be made explicit and the reference included here. Even so, I don\'t quite see how the current findings address the later Campbell observations in any substantial way.

14\) \"\[...\] suggesting that the SAH domain is not required for the function of the CPC proximal to the centromere.\" What do the authors mean by \"proximal to the centromere?\" My understanding is that CPC has multiple functions, likely corresponding to distinct modes of localization: (1) KT-bound CPC localizes, as shown here, through COMA; 2) MT/spindle-bound CPC localizes through Sli15 and is regulated by CDK; 3) CPC targets chromatin through a poorly-defined localization pathway that probably differs in yeast and vertebrates and that corresponds to H3 phosphorylation throughout the pericentromere. This third pathway appears to be disabled by the Sli15dN allele, but this property has been a source of some confusion, because whether CPC localizes to the centromere seems to depend on MT attachment status and the cell cycle. The third pool of CPC must sense cell-cycle regulation as it appears to be involved in chromosome condensation. It is unclear which CPC population the authors refer to in the statement quoted above. If it\'s the third, then they need to look at pH3. If they would rather not address this difficult topic, then the sentence should be rewritten to clarify this point.

15\) Subsection "Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a sli15ΔN mutant upon Ctf19 depletion", last paragraph: The text references Figure 5E but makes no mention of the benomyl experiment. How do the authors interpret this experiment (see also comments in the summary)?

16\) Subsection "The Ame1/Okp1 heterodimer directly links Cse4 nucleosomes to the outer kinetochore", first paragraph: condense this paragraph. Don\'t rehearse all the data: just summarize the results in 2-3 sentences and end with the conclusion stated at the end of the aforementioned paragraph.

17\) \"As MTW1c recruitment by Mif2 and Cnn1 are redundant \[...\]\" There are at least two issues with this statement. First, there is no definitive evidence that yeast Cnn1 recruits MIND. There is, however, good evidence that Cnn1 interacts with Spc24/25. Second, although the two Ndc80 recruitment modules (Cnn1N and MIND via Mif2N) appear redundant, they likely serve distinct functions at different times during the cell cycle. Indeed, the two recruitment modules appear to be tightly regulated by phosphorylation, and different sets of kinases regulate the relevant components.

18\) \"Ame1/Okp1 is the sole essential link of the centromeric nucleosomes to the outer kinetochore \[...\]\" This statement is too strong. First, the authors have not conclusively shown that the phenotypes they observe are due to impaired Okp1-Ame1 recruitment. Second, the double mutant Cnn1d Mif2dN strain is sick and especially so at elevated temperature (Hornung, 2014). Would this not also be an essential link? Third, Mif2N and Ame1N appear to be two parts of the same connection to MIND. The authors must be explicit about necessary and sufficient conditions here, otherwise the above statement is vague and potentially misleading.

19\) \"is consistent with our finding of Chl4/Iml3 being positioned distal from Cse4\" The authors have not positioned Chl4/Iml3 with respect to Cse4. Instead, they have not found any conclusive evidence that Chl4/Iml3 and Cse4 are near each other. Surely, Chl4 binds DNA. Would this DNA binding be carried out distal to the Cse4 nucleosome? How distal?

20\) \"The distinct architectures of vertebrate and budding yeast inner kinetochores \[...\]\" The authors have not shown conclusively that the \"architectures\" differ substantially. Although they have shown that Cse4/CENP-A engagement may differ, it is unclear by how much they differ, to what extent experimental differences contributed to the perceived divergence, and whether the apparent differences actually reflect differential regulation in yeast and vertebrate cells. The above statement should be amended to reflect this uncertainty. If the authors wish to state that there are substantial differences, they should present this as a hypothesis and not a direct observation arising from their data. In general, this section would benefit from a direct comparison with the crosslinking data presented in the Weir paper (human kinetochore crosslinking mass-spectrometry), of which Herzog was a co-author. An overall assessment of the ways these maps agree and differ would be helpful. In any case, the last three sentences of the subsection "Dual recognition of Cse4 at point centromeres by a CCAN architecture distinct from vertebrate regional centromeres" are unduly speculative, so if the authors do not wish to make the Weir comparison explicitly, they should delete most or all of those sentences, as they distract from the genuinely novel findings about CPC tethering.

21\) \"Ctf19 or Mcm21 become essential for viability once Sli15 loses its ability to be recruited to the inner centromere\" The authors struggle to differentiate between CPC localization modes. In this case, the error is grave, as Campbell and Desai showed that the Sli15dN mutant does indeed localize to centromeres, although less efficiently than Sli15WT. Further, it seems the point of this manuscript is that Ctf19 supports centromeric Sli15 localization in the absence of Sli15N. Conceivably, the authors mean to differentiate between KT and inner centromere localization, but my understanding is that the \"inner centromere\" (what I would call pericentromeric) localization of CPC is poorly worked out and has not been knowingly experimentally separated from KT-mediated localization.

22\) Subsection "COMA and its role in positioning Sli15/Ipl1 at the inner kinetochore", second paragraph: \"in trans\" This is vague. Just removing these two words would clarify substantially and adding \"by endogenous Sli15dN through its SAH domain\".

23\) \"\[...\] that facilitates the selective recognition and destabilization of erroneous microtubule attachments upon loss of tension.\" This statement is not only unsupported by the data presented, it is at odds with Figure 5F. If Ctf19-bound CPC is the pool that does tension sensing, then the Sli15dN allele should not cause cells to be sicker than WT on benomyl. Instead, Sli15dN, when present as the only nuclear copy of Sli15, does not support viability on benomyl. This suggests the authors have found a CPC function at the inner KT that is distinct from correcting MT-KT attachment errors and that Sli15N is responsible for tension sensing. Does this KT-specific function reflect a role for CPC in kinetochore assembly? This should be discussed in the text. Might this reflect the possibly that distinct CPC populations do Dsn1 phosphorylation and DASH phosphorylation? Is there another CPC substrate at the inner-KT that is important and that we don\'t yet know about? Finally, with regard to this point, how do the authors reconcile this finding with Supplementary Figure 2C from Campbell and Desai? Those authors did not see a viability defect when they looked at sli15dN on benomyl. Could this reflect differences in the experimental setup?

24\) \"required for cohesin loading\" A minor error: the Ctf19 fragment is required to recruit Scc2/4 to centromeres in late G1 but not for general cohesin loading.

25\) Figure 1A: The concentration of NCP (and consequently the tested protein) used is not listed anywhere in the manuscript. This also applies to Figure 3B. Usually, EMSAs are done with very low concentrations of the labeled reagent (DNA here) and a range of concentrations for the tested binder. The authors have therefore set these up slightly unconventionally. That\'s fine, as long as they specify the conditions clearly.

26\) Figure 1B: Why are Nkp1/2 apparently so large? Why are Cnn1/Wip1 so small, and where is Cnn1? What is the double band at \~25 kDa for both nucleosome preparations?

27\) Figure 2A: What do the symbols beneath the alignment mean? They are not referenced in the figure legend. The protein shown in the alignment (also for B) needs to be specified in the figure so that a fast reader does not have to consult the legend.

28\) Figure 2C: What are the \"tags\" referred to in the figure? These appear to be different preparations than those used in Figure 1, but there is only one type of co-expression vector listed in the supplement.

If the authors remove panel F, as requested below, then panel 2C could be rearranged to make it more readable. Specifically, the Cse4 mutant being tested should be written in larger font, and the cartoons showing each test should be removed.

29\) Figure 2F: Remove this panel. It confuses and does not add meaningful information. Why are Cse4END and Okp1 both red? Why are structural models shown for both peptides, as no published experimentally-determined structure exists for either?

30\) Figure 3A: The protein being shown in the figure needs to be specified clearly in the figure itself. Can the colors for the three lines be either all the same or more different? It\'s difficult to read as is. Also, I think including the ∆ is unnecessary here, although it is important in panel B.

31\) Figure 3B: The ladder should be removed.

32\) Figure 4B: Why does the full COMA pull down less efficiently than Ctf19-Mcm21 alone? Why did the authors not test Sli15-Ipl1 phosphorylation with Ctf19-Mcm21 alone?

I would also suggest putting the legend beneath the gels to make the results easier to interpret.

33\) Figure 4D: What is the lower Ipl1 band/fragment, and why is it apparently missing from the pulled-down material for P4, P6, and P7?

34\) Figure 6: Do the authors really believe Mhf1/2 participate in a nucleosome-like particle with Cnn1-Wip1? This should be discussed.

35\) How does this work affect one\'s reading of Boekmann et al., which describes phosphorylation sites in Cse4N (thought to be Ipl1 sites) and a synthetic interaction between ipl1-ts and mutations at these phosphorylated residues?

36\) The authors should cite and discuss the recent work from Ehrenhofer-Murray (Anedchenko et al., 2019). This group found the same Cse4-Okp1 interaction and has also described Cse4 modifications that influence this interaction.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Interaction of Sli15/Ipl1 with the COMA complex is required for accurate chromosome segregation in budding yeast\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Anna Akhmanova as the Senior Editor, and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) The chromosome loss assay described in Figure 6 (and the paragraph discussing it) should be removed from the paper. In such an assay, completely red colonies cannot be interpreted as 100% chromosome loss. If colonies are completely red (which they are in this case), it suggests that the strain does not have the minichromosome and that it was lost at some unknown point during the experiment.

2\) Based on the removal of the chromosome loss assay, the manuscript title should be revised.

10.7554/eLife.42879.026

Author response

> Essential revisions (experimental):
>
> 1\) The discovery of a potentially new binding site for the CPC at the inner centromere is an important advance, but there is no demonstration that this interaction site exists in vivo, nor what the phenotypes of impairing this interaction are. While the tethering experiments are compelling, the authors \"anchor-away\" the entire Ctf19 protein, which leaves open the possibility that the phenotypes are due to multiple Ctf19 functions. An attempt to analyze Ipl1 localization in vivo or show that error correction requires the interaction between Ipl1 and Ctf19 would strengthen the findings. Ideally, the authors would use their conditional system to show that the mutation of the Ctf19 binding site eliminates all Ipl1 from kinetochores when the Sli15 N-terminus is mutated. At a minimum, the authors should analyze bi-orientation in a Sli15 mutant in the Ctf19 binding site to show that the cells are dying due to a bi-orientation defect as expected.

We agree with the reviewer that assessing the effect of the perturbed interaction between Ctf19/Mcm21 and Sli15/Ipl1 on kinetochore localization of Sli15/Ipl1, chromosome biorientation and segregation, is inevitable for understanding the functional implications of the in vitro identified binding interface. Indeed, we invested quite some time and effort, even before the initial submission of the manuscript, to monitor Sli15 localization to the kinetochore upon Ctf19 depletion in a sli15ΔN background using IF microscopy.

In January, the Tanaka lab posted a preprint of a related study reporting very similar conclusions by a complementary approach. The Tanaka lab applied a more sophisticated system with the auxin-inducible degradation of Mcm21 and Bir1 and the centromere reactivation assay. By quantifying the Ipl1 signal only at kinetochores that had not been recaptured by microtubules, they clearly showed the effect of the Sli15 N-terminal deletion and degradation of Mcm21 and Bir1 on the kinetochore recruitment of Ipl1.

For these reasons and due to the time constraints, we refrained to reproduce this result. Instead, we used our artificial tethering approach to investigate whether a Ctf19ΔC-Okp1 fusion protein, that causes synthetic lethality in the sli15ΔN background, displays chromosome segregation defects in the SLI15 background. Using a minichromosome segregation assay we found that cells upon anchoring-away endogenous Ctf19 and ectopically expressing Ctf19ΔCOkp1 exhibited 100% segregation defect whereas expressing Ctf19-Okp1 resulted in 31% red/sectored colonies and rescue with wild-type Ctf19 displayed 22% red/sectored colonies. The deletion of the Sli15 in vitro binding site on Ctf19 thus correlates with a strong segregation defect in the SLI15 background (Figure 6).

> 2\) It is difficult to see some of the proposed interactions in Figure 4B \-- quantification of this binding experiment would be useful. An additional issue with this figure, which is crucial to the manuscript as a whole, is that pulled-down material for single inputs alone (Sli15/Ipl1, Ame1/Okp1, Ctf19/Mcm21, etc.) are not shown, making the experiment difficult to interpret. These controls should be included.

We have split up the Figure 4B into 4B, 4C and 4D and included the requested single input lanes in 4B. The experiment in 4C shows the effect of the deletion of RWD-C in Ctf19 on the Sli15 binding of Ctf19/Mcm21 together with the quantification of this experiment in 4D. We did not quantify the experiment in 4B as the phosphorylation/dephosphorylation resulted in shifts and smearing of the Sli15 band which prevented a direct comparison between the three (native, autophosphorylated, dephosphorylated) Sli15/Ipl1 conditions. Ctf19/Mcm21 and Ame1/Okp1 bind Sli15/Ipl1 and the interaction is abrogated upon Sli15/Ipl1 autophosphorylation. Moreover, binding of Ctf19/Mcm21 critically depends on the Ctf19 Cterminal RWD domain. An interpretation beyond these obvious conclusions requires additional experiments with a different set up to assess Sli15/Ipl1 interactions in the context of larger kinetochore assemblies.

> 3\) The authors demonstrate that phosphorylation of Sli15 by Ipl1 negatively regulates CPC binding to Ctf19, but there is no indication that this is physiologically relevant. If possible, the authors should test if the phospho-mutants (or mimics) have an effect on viability or chromosome segregation.

We tested the Sli15 phosphorylation-mimicking mutants indicated in the (original) Figure 4C, 4D and deletion mutants of the P4 (aa 350-490) region for cell growth, benomyl sensitivity and for their ability to segregate a centromeric plasmid. The phenotypes of the different mutants were very subtle and did not support functional conclusions or further interpretation. In addition, we repeated the in vitro binding assay with an extended set of mutants in order to assess the Ctf19 binding site on Sli15. This strategy did not result in a reproducible identification of a distinct Sli15 region mediating the Ctf19 interaction. Due to the subtle phenotypes and the ambiguous results of the in vitro binding assay we have decided to withdraw the Figure 4C and 4D from the manuscript. We think that characterization of the Ctf19 binding site on Sli15 will require further screening with an extended set of mutants which eventually will identify mutants for the functional analysis of their implications in chromosome biorientation and segregation.

> 4\) Related to the above point, the authors expressed Sli15-Ipl1 in insect cells and show basal phosphorylation. Might there be some level of phosphorylation that impacts COMA interaction before ATP treatment? It would be informative to test if the interaction is positively affected after treatment with lambda phosphatase.

As suggested by the reviewer we have included Sli15/Ipl1 that was dephosphorylated on beads by lambda phosphatase prior to incubation with Ame1/Okp1 and Ctf19/Mcm21. We did not monitor the dephosphorylation step by mass spectrometry, but SDS-PAGE and Coomassie staining showed a more focused band of Sli15 upon dephosphorylation and the levels of the bound proteins did not grossly change upon dephosphorylation.

> 5\) Figures 2D, 5D and 5E: Immunoblots to demonstrate protein expression should be included.

We have included the requested immunoblots in the respective panels.

> Essential revisions (non-experimental):
>
> 1\) \"Epigenetically marked\" is inappropriate for budding yeast.

We have changed the phrase accordingly.

"Kinetochore assembly is restricted to centromeres, chromosomal domains that are marked by the presence of the histone H3 variant Cse4^CENP-A^".

> 2\) Introduction, third paragraph: The end of this paragraph needs to be rewritten. The authors say that Campbell showed Sli15dN could still localize to kinetochores. They then discuss centromere-targeting deficient Sli15/Ipl1. Which is it? If the authors are referring to distinct Sli15/Ipl1 pools (kinetochore versus centromere?), then they should make the reference to distinct pools explicit and substantiate them with the proper references.

Here, we described the findings of Campbell and Desai, in particular, the altered localization pattern of Sli15 upon deletion of the N-terminus. In budding yeast, CPC is recruited through Ndc10 and through the localization of shugoshin to H2A phosphorylated by Bub1 whereas the latter has not been fully experimentally established in budding yeast (to our knowledge). Whether these two recruitment pathways result in distinct CPC pools with distinct functions and localizations in early mitosis remains to be shown. Moreover, H2A bound shugoshin and Ndc10 may be localized in very close proximity at centromeric nucleosomes raising the possibility that the scaffold of Sli15^INCENP^ extends to and positions Ipl1 at the kinetochore structure.

We do not see the contradiction in referring to Sli15ΔN as centromere-targeting deficient and kinetochore-localized at the same time. We agree with the reviewer that the alternating use of inner centromere, centromere or kinetochore localization is confusing. We have rephrased the paragraph.

For the description of our data we have thus used \'centromere/inner kinetochore\' localization for Sli15 wild-type and \'inner kinetochore\' localization for Sli15ΔN according to the overall localization patterns reported by Campbell and Desai and the observation that Ame1 has a role in Sli15 \'kinetochore-localization\' by Knockleby and Vogel, 2009.

"A recent study by Campbell and Desai challenged this model by showing that a mutant version of Sli15 lacking the centromere-targeting domain, Sli15∆N2-228 (Sli15∆N), suppresses the deletion phenotypes of Bir1, Nbl1, Bub1 and Sgo1 that mediate recruitment of the CPC to the centromere. \[...\] These findings suggest that centromere-targeting of Sli15/Ipl1 is largely dispensable for error correction and SAC signalling. But a molecular understanding of how the inner-kinetochore localised Sli15∆N/Ipl1 retains its biological function is missing."

> 3\) Introduction, last paragraph: Topology is the wrong word.

We have changed the phrase accordingly.

"We describe here the use of chemical crosslinking and mass spectrometry (XLMS) together with biochemical reconstitution to characterize the CTF19c^CCAN^ subunit connectivity and the protein interfaces that establish a selective Cse4-NCP binding environment".

> 4\) \"The interaction is not mediated by AT-rich DNA sequences\" should say, \"The interaction does not require AT-rich DNA sequences.\"

We have changed the phrase accordingly.

"The lack of interaction with H3-NCPs, which were reconstituted using the same 601 DNA sequence, suggests that Ame1/Okp1 directly and selectively binds Cse4 and that the interaction does not require AT-rich DNA sequences as previously proposed".

> 5\) Subsection "The Ame1/Okp1 heterodimer selectively binds Cse4 containing nucleosomes", last paragraph: The authors describe crosslinks between Mif2n and MIND. Did they use the Dsn1-2D mutant? If not, they should comment on the prevalence of these crosslinks relative to expectations. Why do they see them at all?

We used wild-type MTW1c lacking the Dsn1 S240 and S250 phosphomimetic mutations. As outlined in the text, wild-type MTW1 did form a complex with Mif2 and Ame1/Okp1 on SEC which sufficiently served the purpose of the experiment. We did not investigate the effect of Dsn1-2D on the subunit connectivity between MTW1c and the inner kinetochore (Dimitrova et al., 2016).

"In all in vitro reconstitution and XLMS experiments we used wild-type MTW1c purified from *E. coli* and lacking the phosphorylation mimicking mutations of Dsn1 S240 and S250, which were found to stabilize the interaction with Mif2^CENP-C^ and Ame1 but were not required for complex formation on SEC columns (Figure 2C, Figure 1---figure supplement 1)".

> 6\) Results, subsection "The Ame1/Okp1 heterodimer selectively binds Cse4 containing nucleosomes" last paragraph: \"no direct interaction\" is not formally correct. See Schmitzberger, 2017 supplement.

We have changed the phrase accordingly.

"A direct interaction between COMA and in vitro translated Chl4 was reported previously and the Ctf19/Mcm21 heterodimer was found to be required for the kinetochore localization of Chl4 and Iml3".

> 7\) The following is not a correct conclusion: \"Chl4, in contrast to its human ortholog, does not recognize Cse4-NCPs.\" The strongest claim that can be made is that the authors have not found evidence supporting this idea. Nor do the published XLMS data for the human ortholog provide such evidence \-- only direct binding and a structure. One could imagine a number of reasons for absence of crosslinks: no lysine pairs accessible to BS3 link Chl4 and Cse4; 601 is an inappropriate DNA substrate to use for these studies; post-translational modifications are required for Chl4-Cse4 engagement. In short, although the data are clear on many points and extremely valuable overall, they cannot prove the negative.

We agree with the reviewer and have changed the phrase accordingly. We also adapted the respective paragraph in the Discussion (see Essential revisions (non-experimental) 19) in order to avoid an overstatement of the experimental results.

"In contrast to the EMSA titration of human CCAN complexes with CENP-A-NCP using 10 nM NCP mixed with up to 20-fold excess of the respective complex, we could not detect Cse4-NCP band shifts with Chl4/Iml3, the orthologs of human CENP-NL, and with Mcm16/Ctf3/Mcm22, the orthologs of human CENP-HIK (no *S. cerevisiae* ortholog of CENP-M has been identified) using 500 nM NCP mixed with a twofold excess of the CTF19c subcomplexes".

> 8\) \"END domain\" is redundant.

We have corrected this redundancy in the entire manuscript.

> 9\) \"suggests that recruitment of the Ame1/Okp1 heterodimer\" This should be rewritten to clarify the point that the suggested recruitment relationship between Cse4-END and Okp1-Ame1 is the speculation here. This modification is important; although the evidence presented is consistent with recruitment (Okp1-Ame1 by Cse4), no conclusive test of such a relationship is presented. An alternative hypothesis -- that Cse4-END regulates an essential function of either Okp1-Ame1 or Cse4 -- is equally likely given the data.

We agree with the reviewer and have changed the phrase accordingly.

"The observation that deletion of the minimal Ame1/Okp1 interacting Cse4 motif (aa 34-46) correlates with the loss of cell viability, whereas the C-terminal half of the END (aa 48-61) is neither essential for viability nor required for Ame1/Okp1 association suggests that binding of the Ame1/Okp1 heterodimer to Cse4 residues 34-46 is essential for yeast growth".

> 10\) \"Ctf19 is the primary Sli15/Ipl1 interaction site \[...\]\" This statement is too strong. Instead, it should read \"is required for Sli15/Ipl1 interaction\"

We agree with the reviewer and have changed the phrase accordingly.

"In agreement with previous findings recombinant Ctf19ΔC formed a stoichiometric complex with Mcm21, but lost its ability to bind Sli15/Ipl1 indicating that the RWD-C domain of Ctf19 is required for Sli15/Ipl1 interaction with Ctf19/Mcm21 in vitro (Figure 4B)".

> 11\) Subsection "Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a sli15ΔN mutant upon Ctf19 depletion", last paragraph: This paragraph should be split into at least two and possibly three or four paragraphs.

We split up this section into two paragraphs.

> 12\) Subsection "Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a sli15ΔN mutant upon Ctf19 depletion", last paragraph: That Ctf19dN is not synthetic with Sli15dN is both interesting and important. If impaired cohesin loading does not explain the synthetic interaction with Ctf19d (as apparently it does not), how would the authors interpret the finding from Campbell and Desai that Ctf19d is synthetic with Sli15dN? When this finding was originally presented, it was framed as evidence for the cohesin hypothesis, which here seems discredited. A single sentence in the Discussion section would be appropriate.

We have included the following sentence.

"Moreover, assessing the initially proposed model by Campbell and Desai (Campbell and Desai, 2013) for the synthetic growth defect of Ctf19/Mcm21 deletion in a sli15ΔN background, we observed that deletion of the Ctf19 N-terminus, previously shown to be required for recruiting the cohesin loading complex Scc2/4 (Hinshaw et al., 2017), did not cause a synthetic effect in sli15ΔN mutant cells. This result indicated that the synthetic effect with the Sli15 N-terminal deletion is mediated by a Ctf19 domain distinct from its N-terminus and its role in cohesin loading".

> 13\) \"Endogenous Sli15dN could not rescue in trans \[...\]\" and \"In contrast, deletion of the SAH domain in Ame1- and Okp1-Sli14dNdSAH fusions was not lethal and could be rescued in trans.\" These statements are vague. Could not be rescued by what in trans? I suspect this is a reference to later Campbell work (Fink et al., 2017) showing that induced dimerization of Sli15 rescues viability of cells expressing more perturbative Sli15dN alleles (d2-500, for instance). If so, this should be made explicit and the reference included here. Even so, I don\'t quite see how the current findings address the later Campbell observations in any substantial way.

We agree that these statements are vague and thus, have rephrased the paragraph as indicated below. Indeed, we did not intend to address the Fink et al. 2017 observation that dimerization rescues the otherwise lethal N-terminal truncations of Sli15.

"Hence, since the ectopically expressed fusion proteins were tested in the sli15ΔN background, the result indicates that Ipl1 activity associated with endogenous Sli15ΔN could not rescue synthetic lethality and that tethering Ipl1 activity to COMA subunits is crucial. In contrast, deletion of the SAH domain in Ame1- and Okp1Sli15∆N∆SAH fusions was not lethal and was presumably rescued by the SAH domain of the endogenous Sli15ΔN protein (Figure 5D) suggesting that the SAH domain is not required for the function of the inner kinetochore-localized CPC pool".

> 14\) \"\[...\] suggesting that the SAH domain is not required for the function of the CPC proximal to the centromere.\" What do the authors mean by \"proximal to the centromere?\" My understanding is that CPC has multiple functions, likely corresponding to distinct modes of localization: (1) KT-bound CPC localizes, as shown here, through COMA; 2) MT/spindle-bound CPC localizes through Sli15 and is regulated by CDK; 3) CPC targets chromatin through a poorly-defined localization pathway that probably differs in yeast and vertebrates and that corresponds to H3 phosphorylation throughout the pericentromere. This third pathway appears to be disabled by the Sli15dN allele, but this property has been a source of some confusion, because whether CPC localizes to the centromere seems to depend on MT attachment status and the cell cycle. The third pool of CPC must sense cell-cycle regulation as it appears to be involved in chromosome condensation. It is unclear which CPC population the authors refer to in the statement quoted above. If it\'s the third, then they need to look at pH3. If they would rather not address this difficult topic, then the sentence should be rewritten to clarify this point.

We have changed the phrase accordingly. Deletion of the yeast haspin-like kinases ALK1 and ALK2 does not result in a synthetic growth defect in a sli15ΔN background and thus, it is unclear whether the H3-T3-P dependent mechanism operates in yeast (Campbell and Desai, 2013).

"\[...\] suggesting that the SAH domain is not required for the function of the inner kinetochore-localized CPC pool".

> 15\) Subsection "Tethering Sli15ΔN selectively to COMA rescues the synthetic lethality of a sli15ΔN mutant upon Ctf19 depletion", last paragraph: The text references Figure 5E but makes no mention of the benomyl experiment. How do the authors interpret this experiment (see also comments in the summary)?

We attribute this discrepancy between our results and the findings made by Campbell and Desai to different experimental conditions. As we have repeatedly seen the benomyl sensitivity of the Sli15ΔN mutant, we think it is important to include this observation in the manuscript. A recent paper by the Kelly lab (Haase et al., 2017) showing that in *Xenopus* egg extracts CPC lacking the CEN domain of INCENP affected the inner kinetochore composition and the correction of erroneous kinetochore-microtubule attachments. They discussed that the centromere-targeting may be important for establishing a sharp phosphorylation gradient as it has been proposed for the spatial separation model of error correction. But even \'noncentromeric\' inner kinetochore-localized CPC may establish a flat gradient and intermediate levels of Ndc80 phosphorylation that prevent attachment errors, especially in yeast with kinetochores attached to one microtubule, unless cells are challenged by microtubule depolymerization.

We have modified the paragraph in order to describe the different experimental set-ups.

"Cells ectopically expressing the Sli15∆N mutant protein grew like wild-type, but displayed sensitivity to 15 µg/ml benomyl which contrasted the observation by Campbell and Desai that cells carrying the endogenous sli15ΔN allele were not sensitive to 12.5 µg/ml benomyl (Campbell and Desai, 2013), hence, these deviating observations may be a result of different experimental conditions".

> 16\) Subsection "The Ame1/Okp1 heterodimer directly links Cse4 nucleosomes to the outer kinetochore", first paragraph: condense this paragraph. Don\'t rehearse all the data: just summarize the results in 2-3 sentences and end with the conclusion stated at the end of the aforementioned paragraph.

We are grateful for the suggestion and have shortened the paragraph.

"We investigated the subunit connectivity of the inner kinetochore assembled at budding yeast point centromeres at the domain level using in vitro reconstitution and XLMS. We found that in addition to Mif2 (Xiao et al., 2017), the Ame1/Okp1 heterodimer of the COMA complex is a direct and selective interactor of Cse4-NCPs and characterized the binding interface between Ame1/Okp1 and Cse4. We identified the residues 163-187 of the Okp1 core domain (Figure 3B, C) (Schmitzberger et al., 2017) and the residues 34-46 (Figure 2D, E) of the Cse4 END (aa 28 to 60), which is conserved between interrelated yeast, to establish the interaction. The notion that the essential function of the Cse4 N-terminus and the binding interface for Ame1/Okp1 are mediated by the same 13 amino acid motif suggests that the interaction of Ame1/Okp1 with Cse4 is essential in budding yeast".

> 17\) \"As MTW1c recruitment by Mif2 and Cnn1 are redundant \[...\]\" There are at least two issues with this statement. First, there is no definitive evidence that yeast Cnn1 recruits MIND. There is, however, good evidence that Cnn1 interacts with Spc24/25. Second, although the two Ndc80 recruitment modules (Cnn1N and MIND via Mif2N) appear redundant, they likely serve distinct functions at different times during the cell cycle. Indeed, the two recruitment modules appear to be tightly regulated by phosphorylation, and different sets of kinases regulate the relevant components.

We have rephrased the paragraph as indicated below in order to make a clear statement. We refrain from discussing the different pathways of NDC80 and MTW1 recruitment and their regulation in detail as this goes beyond the scope of the discussion of this study.

"As NDC80c recruitment by Cnn1 and Mif2 via MTW1c are redundant pathways and become important only if one of the two is compromised, \[\...\]".

> 18\) \"Ame1/Okp1 is the sole essential link of the centromeric nucleosomes to the outer kinetochore \[...\]\" This statement is too strong. First, the authors have not conclusively shown that the phenotypes they observe are due to impaired Okp1-Ame1 recruitment. Second, the double mutant Cnn1d Mif2dN strain is sick and especially so at elevated temperature (Hornung, 2014). Would this not also be an essential link? Third, Mif2N and Ame1N appear to be two parts of the same connection to MIND. The authors must be explicit about necessary and sufficient conditions here, otherwise the above statement is vague and potentially misleading.

Deletion of the N-terminal 15 amino acids of Ame1 is lethal whereas the Mif2 N-terminus or Cnn1 are not essential for cell growth and the double mutant Mif2ΔN cnn1Δ shows a growth defect which is enhanced at higher temperature (Hornung et al., 2014). The role of Mif2 in linking the outer kinetochore and Cnn1 are thus not essential for cell growth.

As the essential function of the Cse4 N-terminus and the binding interface for Ame1/Okp1 are mediated by the same 13 amino acid motif we describe Ame1/Okp1 as the essential link of nucleosomes to the outer kinetochore. We have modified the text as indicated below.

"Although, we did not address whether the Cse4 residues 34-46 are essential for

Ame1/Okp1 kinetochore recruitment, the notion that the essential function of the Cse4 N-terminus and the binding interface for Ame1/Okp1 are mediated by the same 13 amino acid motif suggests \[...\]".

"\[...\] Ame1/Okp1 is the essential link of the centromeric nucleosomes to the outer kinetochore emphasizing its role as a cornerstone of kinetochore assembly at the budding yeast point centromere".

> 19\) \"is consistent with our finding of Chl4/Iml3 being positioned distal from Cse4\" The authors have not positioned Chl4/Iml3 with respect to Cse4. Instead, they have not found any conclusive evidence that Chl4/Iml3 and Cse4 are near each other. Surely, Chl4 binds DNA. Would this DNA binding be carried out distal to the Cse4 nucleosome? How distal?

We agree with the reviewer and have modified the text accordingly.

"In contrast to Mif2 and Ame1/Okp1, we did not detect complex formation of Chl4/Iml3 with Cse4-NCPs in our EMSA (Figure 1A). Whether this observation can be attributed to the lack of conservation of the RG motif in the corresponding Cse4 sequences in related budding yeasts (Figure 2A), and whether this reflects a different role of Chl4/Iml3 in Cse4 recognition and kinetochore assembly remains to be determined".

> 20\) \"The distinct architectures of vertebrate and budding yeast inner kinetochores \[...\]\" The authors have not shown conclusively that the \"architectures\" differ substantially. Although they have shown that Cse4/CENP-A engagement may differ, it is unclear by how much they differ, to what extent experimental differences contributed to the perceived divergence, and whether the apparent differences actually reflect differential regulation in yeast and vertebrate cells. The above statement should be amended to reflect this uncertainty. If the authors wish to state that there are substantial differences, they should present this as a hypothesis and not a direct observation arising from their data. In general, this section would benefit from a direct comparison with the crosslinking data presented in the Weir paper (human kinetochore crosslinking mass-spectrometry), of which Herzog was a co-author. An overall assessment of the ways these maps agree and differ would be helpful. In any case, the last three sentences of the subsection "Dual recognition of Cse4 at point centromeres by a CCAN architecture distinct from vertebrate regional centromeres" are unduly speculative, so if the authors do not wish to make the Weir comparison explicitly, they should delete most or all of those sentences, as they distract from the genuinely novel findings about CPC tethering.

We agree with the reviewer that this paragraph is speculative and also redundant to some extent. We also refrain to compare the human (Weir et al.) and budding yeast (this study) crosslink networks as conditions and reproducibility of both experiments cannot be assessed to the extent needed for a direct comparison. Thus, we have deleted the entire paragraph.

> 21\) \"Ctf19 or Mcm21 become essential for viability once Sli15 loses its ability to be recruited to the inner centromere\" The authors struggle to differentiate between CPC localization modes. In this case, the error is grave, as Campbell and Desai showed that the Sli15dN mutant does indeed localize to centromeres, although less efficiently than Sli15WT. Further, it seems the point of this manuscript is that Ctf19 supports centromeric Sli15 localization in the absence of Sli15N. Conceivably, the authors mean to differentiate between KT and inner centromere localization, but my understanding is that the \"inner centromere\" (what I would call pericentromeric) localization of CPC is poorly worked out and has not been knowingly experimentally separated from KT-mediated localization.

Campbell and Desai explicitly make the following statement in their paper:

"\[...\] localization of Sli15 and Ipl1 between sister kinetochore clusters (analogous to the inner-centromere localization in other species) was observed following brief microtubule depolymerization in asynchronously growing cells .... In sli15(ΔNT) cells, localization between sister kinetochore clusters was lost for both Sli15(ΔNT) and Ipl1 \[...\]; instead weak localization was observed coincident with kinetochore clusters \[...\] Thus, the Sli15(ΔNT)--Ipl1 complex supports accurate chromosome segregation without enriching between sister kinetochores in vivo".

The localization between sister kinetochore clusters was lost for Sli15ΔN and they referred to this localization also as inner centromere analogous in other species. Furthermore, the localization of Sli15ΔN was termed \'coincident with kinetochore cluster\' indicating the difference in localization pattern by distinct descriptions.

As outlined above, we have thus used \'centromere/inner kinetochore\' localization for Sli15 wild-type and \'inner kinetochore\' localization for Sli15ΔN.

We have rephrased the sentence accordingly.

"Moreover, Ctf19 and Mcm21 become essential when loss of the Sli15 N-terminal segment (Sli15∆N) prevents its targeting to the centromere".

> 22\) Subsection "COMA and its role in positioning Sli15/Ipl1 at the inner kinetochore", second paragraph: \"in trans\" This is vague. Just removing these two words would clarify substantially and adding \"by endogenous Sli15dN through its SAH domain\".

In contrast, deletion of the SAH domain in Ame1- and Okp1-Sli15∆N∆SAH fusions was not lethal and was presumably rescued by the SAH domain of the endogenous Sli15ΔN protein (Figure 5D) suggesting that the SAH domain is not required for the function of the inner-kinetochore localized CPC pool.

> 23\) \"\[...\] that facilitates the selective recognition and destabilization of erroneous microtubule attachments upon loss of tension.\" This statement is not only unsupported by the data presented, it is at odds with Figure 5F. If Ctf19-bound CPC is the pool that does tension sensing, then the Sli15dN allele should not cause cells to be sicker than WT on benomyl. Instead, Sli15dN, when present as the only nuclear copy of Sli15, does not support viability on benomyl. This suggests the authors have found a CPC function at the inner KT that is distinct from correcting MT-KT attachment errors and that Sli15N is responsible for tension sensing. Does this KT-specific function reflect a role for CPC in kinetochore assembly? This should be discussed in the text. Might this reflect the possibly that distinct CPC populations do Dsn1 phosphorylation and DASH phosphorylation? Is there another CPC substrate at the inner-KT that is important and that we don\'t yet know about? Finally, with regard to this point, how do the authors reconcile this finding with Supplementary Figure 2C from Campbell and Desai? Those authors did not see a viability defect when they looked at sli15dN on benomyl. Could this reflect differences in the experimental setup?

Here, we also would like to refer to our response to comment 15.

Indeed, we believe that the observed benomyl sensitivity upon nuclear depletion of endogenous Sli15 and ectopic expression of Sli15ΔN is attributed to the different experimental conditions in comparison to the work of Campbell and Desai. The finding that Ame1/Okp1 fused to Sli15ΔN rescued the synthetic lethality of CTF19-FRB/sli15ΔN cells does not contradict the observed benomyl sensitivity of Sli15ΔN as only nuclear copy.

Whether this benomyl sensitivity indicates a role for the centromere-targeting of Sli15 in tension sensing, error correction or a yet unknown function is highly speculative and requires thorough further analysis. Based on the observations of Haase et al. (see also comment 15.) the centromere-targeting domain could be indeed important for tension sensing and/or for establishing a sharp phosphorylation gradient.

We have added the following paragraph to the description of the model in the caption of Figure 7.

"In line with the observed benomyl sensitivity of cells expressing Sli15ΔN as the only nuclear copy, a recent study in *Xenopus* egg extracts found that CPC lacking the CEN domain of INCENP affected the correction of erroneous kinetochore-microtubule attachments (Haase et al., 2017). \[...\] Flat Ndc80 phosphorylation levels could be sufficient for the non-selective turnover of erroneous kinetochore, especially at budding yeast kinetochores which are attached to a single microtubule, unless cells are challenged by microtubule poisons".

> 24\) \"required for cohesin loading\" A minor error: the Ctf19 fragment is required to recruit Scc2/4 to centromeres in late G1 but not for general cohesin loading.

We have deleted this passage in the figure legend (Figure 5A) as it is redundant to the main text where we described it as suggested by the reviewer.

> 25\) Figure 1A: The concentration of NCP (and consequently the tested protein) used is not listed anywhere in the manuscript. This also applies to Figure 3B. Usually, EMSAs are done with very low concentrations of the labeled reagent (DNA here) and a range of concentrations for the tested binder. The authors have therefore set these up slightly unconventionally. That\'s fine, as long as they specify the conditions clearly.

We have mentioned the concentrations in the Materials and methods section and also described the experimental conditions in the text.

"\[...\] using 500 nM NCP incubated with a twofold excess of the complexes".

> 26\) Figure 1B: Why are Nkp1/2 apparently so large? Why are Cnn1/Wip1 so small, and where is Cnn1? What is the double band at \~25 kDa for both nucleosome preparations?

The labelling of the different protein complexes was mixed up and has been corrected.

> 27\) Figure 2A: What do the symbols beneath the alignment mean? They are not referenced in the figure legend. The protein shown in the alignment (also for B) needs to be specified in the figure so that a fast reader does not have to consult the legend.

We have indicated the proteins in Figure 2A and 2B and have described the symbols in the figure caption.

> 28\) Figure 2C: What are the \"tags\" referred to in the figure? These appear to be different preparations than those used in Figure 1, but there is only one type of coexpression vector listed in the supplement.

We have specified the tags in Figure 2C and added a description to the figure legend Figure 1B.

"\[...\[individual proteins, recombinantly purified from *E. coli*, used \[...\]".

> If the authors remove panel F, as requested below, then panel 2C could be rearranged to make it more readable. Specifically, the Cse4 mutant being tested should be written in larger font, and the cartoons showing each test should be removed.

We have removed Figure 2F and adapted Figure 2C according to the reviewer\`s suggestion.

> 29\) Figure 2F: Remove this panel. It confuses and does not add meaningful information. Why are Cse4END and Okp1 both red? Why are structural models shown for both peptides, as no published experimentally-determined structure exists for either?

We agree with the reviewer and have removed this panel.

> 30\) Figure 3A: The protein being shown in the figure needs to be specified clearly in the figure itself. Can the colors for the three lines be either all the same or more different? It\'s difficult to read as is. Also, I think including the ∆ is unnecessary here, although it is important in panel B.

We have corrected Figure 3 according to the reviewer´s suggestions.

> 31\) Figure 3B: The ladder should be removed.

We have corrected Figure 3B according to the reviewer´s suggestion.

> 32\) Figure 4B: Why does the full COMA pull down less efficiently than Ctf19-Mcm21 alone? Why did the authors not test Sli15-Ipl1 phosphorylation with Ctf19-Mcm21 alone?
>
> I would also suggest putting the legend beneath the gels to make the results easier to interpret.

Up to now, we do not have any experimental data explaining the less efficient binding of COMA to Sli15/Ipl1 in comparison to the individual Ctf19/Mcm21 and Ame1/Okp1 complexes. As we have added Ctf19/Mcm21 and Ame1/Okp1 as individual complexes in an equimolar ratio we speculate that under the experimental conditions Ctf19/Mcm21 and Ame1/Okp1 do not completely assemble into the COMA complex and/or that they compete for overlapping binding sites on Sli15 in the absence of other binding partners like the Cse4NCP or Bir^Survivin^ and Nbl1^Borealin^ in vitro. Based on our crosslinking data we focused on the characterization of the Sli15-Ctf19 interaction and did not further address the binding to Ame1/Okp1.

> 33\) Figure 4D: What is the lower Ipl1 band/fragment, and why is it apparently missing from the pulled-down material for P4, P6, and P7?

We have analysed both protein bands by in-gel digest and mass spectrometry. Both bands have been identified as Ipl1 suggesting that the lower band is a degradation product of Ipl1.

The lower band might have been lost during the washing procedure of the pull-down. Eventually, we have removed Figure 4D what we explain in detail in the response to the essential experimental revisions.

> 34\) Figure 6: Do the authors really believe Mhf1/2 participate in a nucleosome-like particle with Cnn1-Wip1? This should be discussed.

We have corrected the (new) Figure 7 as recruitment of Cnn1/Wip1 critically depends on the localization of the Mcm16/Ctf3/Mcm22 complex (CENP-HIK in humans) (Pekgöz Altunkaya et al., 2016; Basilico et al., 2014).

> 35\) How does this work affect one\'s reading of Boekmann et al., which describes phosphorylation sites in Cse4N (thought to be Ipl1 sites) and a synthetic interaction between ipl1-ts and mutations at these phosphorylated residues?

We have cited and discussed the work of Boeckmann et al.

> 36\) The authors should cite and discuss the recent work from Ehrenhofer-Murray (Anedchenko et al., 2019). This group found the same Cse4-Okp1 interaction and has also described Cse4 modifications that influence this interaction.

We have cited and discussed the work of the Ehrenhofer-Murray lab.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Thank you for resubmitting your work entitled \"Interaction of Sli15/Ipl1 with the COMA complex is required for accurate chromosome segregation in budding yeast\" for further consideration at eLife. Your revised article has been favorably evaluated by Anna Akhmanova (Senior Editor), a Reviewing Editor, and 2 reviewers.
>
> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> 1\) The chromosome loss assay described in Figure 6 (and the paragraph discussing it) should be removed from the paper. In such an assay, completely red colonies cannot be interpreted as 100% chromosome loss. If colonies are completely red (which they are in this case), it suggests that the strain does not have the minichromosome and that it was lost at some unknown point during the experiment.

To address the reviewer´s concern that the minichromosome was lost spontaneously during the experiment, we repeated the experiment by plating cells, grown for 4 hours in rich YPD medium, onto synthetic medium in the absence or presence of rapamycin. Colonies on plates lacking rapamycin showed about 3.5 to 7% red/sectored colonies. This demonstrates that the minichromosome is not lost during the experiment and that the minichromosome loss depicted on plates with rapamycin is a consequence of anchoring-away Ctf19 from the nucleus. Furthermore, the rescue of the segregation defect upon the ectopic expression of Ctf19 or Ctf19-Okp1 proteins in contrast to expressing Ctf19ΔC-Okp1 suggested a role of the Ctf19 C-terminus in chromosome segregation.

Indeed, we could not experimentally address the observation that we obtained 100% red/sectored colonies upon Ctf19 depletion. We attribute this to our anchor-away system in combination with possibly suboptimal conditions of the preculture in YPD medium. A thorough optimization of our protocol would have exceeded the time constraints of the revision period.

Apart from this, we think that the current state of the experiment is sufficient to determine the relevance of the Ctf19 C-terminus for chromosome segregation. As we have added the -- rapamycin condition, we can clearly show that the minichromosome loss is a consequence of depleting Ctf19 from the nucleus and not due to a spontaneous loss during the experiment. In total, we have repeated the experiment 9 times showing very similar results with low standard errors. Thus, we are confident that the observed effect upon deletion of the Ctf19 C-terminus is valid. In addition, our findings are consistent with the observation of the Tanaka lab (Garcia-Rodriguez et al., 2019) who used a complementary approach showing that removal of Bir1 or Mcm21 reduced localization of Ipl1 at the centromere and that the effect on Ipl1 localization correlated with the establishment of chromosome biorientation.

Furthermore, we agree with the reviewer´s suggestion to revise the text and have outlined the changes in detail in the response to comment 2.

We have avoided any quantitative numerical statements or comparisons based on the results of the minichromosome loss assay and simply interpret the observed changes as effects upon depletion of Ctf19 or deletion of the Ctf19 C-terminus in the Ctf19-Okp1 fusion protein. Moreover, we have removed the phrase "the Sli15/Ipl1 interaction with Ctf19 is required for chromosome segregation" from the text and replaced it with "the Ctf19 C-terminus \[...\] has a role / is important for \[...\] chromosome segregation \[...\]" or similar phrases.

> 2\) Based on the removal of the chromosome loss assay, the manuscript title should be revised.

We have modified the title.

"The COMA complex interacts with Cse4 and positions Sli15/Ipl1 at the budding yeast inner kinetochore".

We have revised the Abstract.

"Kinetochores are macromolecular protein complexes at centromeres that ensure accurate chromosome segregation by attaching chromosomes to spindle microtubules and integrating safeguard mechanisms. \[...\] This study shows molecular characteristics of the point-centromere inner kinetochore architecture [and]{.ul} suggests a role for the Ctf19 C-terminus in mediating accurate chromosome segregation".

Results:

"Deletion of the Ctf19 RWD-C domain causes a chromosome segregation defect in the Sli15 wild-type background".

"In contrast, Ctf19∆C-Okp1, which was localized at the kinetochore (Figure 6C), was unable to rescue the segregation defect (Figure 6B, Figure 6B---source data 1)".

Discussion, subsection "The Ctf19 C-terminus is required for Sli15/Ipl1 binding in vitro and has a role in accurate chromosome segregation":

"This is consistent with our finding that the Ctf19 C-terminus has a role in accurate chromosome segregation and indicates that the Sli15-Ctf19 interaction contributes to the localization and stabilization of the CPC at the inner kinetochore (Figure 7)."

[^1]: These authors contributed equally to this work.
